<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Vet Sci</journal-id><journal-id journal-id-type="iso-abbrev">J. Vet. Sci</journal-id><journal-id journal-id-type="pmc-domain-id">1103</journal-id><journal-id journal-id-type="pmc-domain">jvetsci</journal-id><journal-id journal-id-type="publisher-id">JVS</journal-id><journal-title-group><journal-title>Journal of Veterinary Science</journal-title></journal-title-group><issn pub-type="ppub">1229-845X</issn><issn pub-type="epub">1976-555X</issn><publisher><publisher-name>The Korean Society of Veterinary Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC5583415</article-id><article-id pub-id-type="pmcid-ver">PMC5583415.1</article-id><article-id pub-id-type="pmcaid">5583415</article-id><article-id pub-id-type="pmcaiid">5583415</article-id><article-id pub-id-type="pmid">28859268</article-id><article-id pub-id-type="doi">10.4142/jvs.2017.18.S1.281</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Development and trial of vaccines against <italic toggle="yes">Brucella</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Lalsiamthara</surname><given-names initials="J">Jonathan</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Lee</surname><given-names initials="JH">John Hwa</given-names></name><xref ref-type="aff" rid="A1"/></contrib></contrib-group><aff id="A1">College of Veterinary Medicine, Chonbuk National University, Iksan 54596, Korea.</aff><author-notes><corresp>
Corresponding author: Tel: +82-63-850-0940; Fax: +82-63-850-0910; <email>johnhlee@jbnu.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>22</day><month>8</month><year>2017</year></pub-date><volume>18</volume><issue>Suppl 1</issue><issue-id pub-id-type="pmc-issue-id">297912</issue-id><fpage>281</fpage><lpage>290</lpage><history><date date-type="received"><day>01</day><month>6</month><year>2017</year></date><date date-type="rev-recd"><day>07</day><month>7</month><year>2017</year></date><date date-type="accepted"><day>14</day><month>7</month><year>2017</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>08</month><year>2017</year></date></event><event event-type="pmc-live"><date><day>05</day><month>09</month><year>2017</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-03-26 20:25:12.437"><day>26</day><month>03</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2017 The Korean Society of Veterinary Science</copyright-statement><copyright-year>2017</copyright-year><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jvs-18-281.pdf"/><abstract><p>The search for ideal brucellosis vaccines remains active today. Currently, no licensed human or canine anti-brucellosis vaccines are available. In bovines, the most successful vaccine (S19) is only used in calves, as adult vaccination results in orchitis in male, prolonged infection, and possible abortion complications in pregnant female cattle. Another widely deployed vaccine (RB51) has a low protective efficacy. An ideal vaccine should exhibit a safe profile as well as enhance protective efficacy. However, currently available vaccines exhibit one or more major drawbacks. Smooth live attenuated vaccines suffer shortcomings such as residual virulence and serodiagnostic interference. Inactivated vaccines, in general, confer relatively low levels of protection. Recent developments to improve brucellosis vaccines include generation of knockout mutants by targeting genes involved in metabolism, virulence, and the lipopolysaccharide synthesis pathway, as well as generation of DNA vaccines, mucosal vaccines, and live vectored vaccines, have all produced varying degrees of success. Herein, we briefly review the bacteriology, pathogenesis, immunological implications, candidate vaccines, vaccinations, and models related to <italic toggle="yes">Brucella</italic>.</p></abstract><kwd-group><kwd><italic toggle="yes">Brucella</italic></kwd><kwd>animal models</kwd><kwd>brucellosis</kwd><kwd>vaccines</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Ministry of Health and Welfare</institution><institution-id institution-id-type="CrossRef">http://dx.doi.org/10.13039/501100003625</institution-id></institution-wrap></funding-source><award-id>HI16C2130</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Recently, brucellosis has garnered increased importance due to its zoonotic potential and possible use in bio-warfare. Though the disease-causal agent relationship was established in the 19th century [<xref rid="B14" ref-type="bibr">14</xref>], it never reached the center of attention in the medical field. In 2009, the World Health Organization's, third International Conference on Neglected Zoonotic Diseases assessed and acknowledged initiative works into the burden of key diseases such as bovine tuberculosis, brucellosis, toxoplasmosis, and zoonotic schistosomiasis [<xref rid="B6" ref-type="bibr">6</xref>]. Brucellosis is a sub-acute or chronic disease, and in cattle, sheep, goats, other ruminants, and pigs the initial phase following infection is often not apparent [<xref rid="B29" ref-type="bibr">29</xref>]. Recently recognized <italic toggle="yes">Brucella</italic> types associated with disease in marine animals may also have the capacity to cause disease in humans [<xref rid="B29" ref-type="bibr">29</xref><xref rid="B72" ref-type="bibr">72</xref>].</p><p>Control of zoonotic diseases in human populations has relied heavily on the control of animal disease. Over the last century, human brucellosis has been controlled by vaccination and culling within cattle, goat, and sheep herds [<xref rid="B28" ref-type="bibr">28</xref>]. Yet, despite past and current efforts to eradicate brucellosis many human cases are reported annually worldwide. There is a direct link between the disease and the economic status of a country [<xref rid="B78" ref-type="bibr">78</xref>]. It was the opinion of experts that resulted in the suggestion that vaccination efforts alone are insufficient to effectively control the disease. Still, the efficacy of vaccination-only strategies has not been seriously evaluated, and it depends in large part on the quality of the vaccine employed [<xref rid="B28" ref-type="bibr">28</xref>]. Since, brucellosis is closely tied to economic stature, improving livelihood would also alleviate disease burden and transmission in endemic areas.</p><p>Due to importance of controlling brucellosis in the animal population, <italic toggle="yes"><italic toggle="yes">Brucella</italic> abortus</italic> S19 and <italic toggle="yes"><italic toggle="yes">Brucella</italic> melitensis</italic> Rev. 1 vaccines have been widely used in certain developed countries, but both the vaccines induce abortions in pregnant animals and are virulent for humans; moreover, they elicit anti-<italic toggle="yes"><italic toggle="yes">Brucella</italic></italic> antibodies that interfere with serodiagnosis. Further, Rev. 1 is streptomycin resistant, an important antibiotic used to treat the disease. However, the residual virulence issue can be solved by using further attenuated mutant strains, and the serodiagnosis problem can be solved by using lipopolysaccharide (LPS)-disrupted mutant strains, immunization via the conjunctival route, avoidance of adult vaccination, and by an individual serological follow up. Hence, a vaccine embodying all such prerequisite properties would be a boon to brucellosis control and a major breakthrough [<xref rid="B70" ref-type="bibr">70</xref><xref rid="B85" ref-type="bibr">85</xref>].</p></sec><sec><title>Understanding <italic toggle="yes">Brucella</italic> for Strategic Development of Vaccine</title><sec><title><italic toggle="yes">Brucella</italic> organism</title><p>Interestingly, <italic toggle="yes">Brucella</italic> organisms are very closely related to plant microbes. It is remarkable how the proto-<italic toggle="yes">Brucella</italic> may jump between the two kingdoms, from plant to animal. <italic toggle="yes">Brucellae</italic> are classified under &#945;-<italic toggle="yes">Proteobacteria</italic> phylogenetically, which are related to plant pathogens and symbionts such as <italic toggle="yes">Rhizobium</italic>, <italic toggle="yes">Agrobacterium</italic>, and an animal endosymbiont <italic toggle="yes">Wolbachia</italic>, to intracellular animal parasites such as <italic toggle="yes">Bartonella</italic> and <italic toggle="yes">Rickettsia</italic>, and to opportunistic and free-living bacteria like <italic toggle="yes">Ochrobactrum</italic> and <italic toggle="yes">Caulobacter</italic> [<xref rid="B32" ref-type="bibr">32</xref><xref rid="B69" ref-type="bibr">69</xref>]. Accurate identification of <italic toggle="yes">Brucellae</italic> and differentiating them from closely related opportunistic <italic toggle="yes">Ochrobactrum</italic> is important for accurate diagnosis [<xref rid="B83" ref-type="bibr">83</xref>]. It is not well understood whether pre-existing anti-<italic toggle="yes">Ochrobactrum</italic> immunity may hinder successful vaccination against <italic toggle="yes">Brucella</italic>. <italic toggle="yes">Brucellae</italic> are gram-negative, non-sporulating, capnophilic, facultative intracellular bacteria [<xref rid="B28" ref-type="bibr">28</xref>].</p></sec><sec><title><italic toggle="yes">Brucella</italic> genetic composition</title><p>With the increased availability of the <italic toggle="yes">Brucella</italic> whole genome sequence, a wide variety of genetic modification studies related to microbiological and vaccinology have been undertaken. The type strains and other representative strains of the six species of <italic toggle="yes">Brucella</italic> form a very tight cluster, with G + C values between 57.9% and 59.2%, DNA homologies close to 100%, T<sub>m</sub> values between 79.2&#8451; and 80.5&#8451;, and rRNA binding values between 0.166% and 0.198% [<xref rid="B32" ref-type="bibr">32</xref>]. <italic toggle="yes">Brucella</italic> species show a considerably high degree of homology, except for <italic toggle="yes">B. ovis</italic> which has been reported to show slight restriction endonuclease digestion pattern differences from other <italic toggle="yes">Brucellae</italic> [<xref rid="B73" ref-type="bibr">73</xref>]. The vaccine strain S19 genome is 3.2 Mbp and comprises two circular chromosomes: one 2122487 bp long and the other 1161449 bp long. The average G + C content of the two chromosomes of S19 strain is 57% [<xref rid="B30" ref-type="bibr">30</xref>]. It was shown that the S19 genome has remarkable similarity in size and structure to those of its virulent relatives, <italic toggle="yes">B. abortus</italic> strains 9&#8211;941 and 2308 [<xref rid="B22" ref-type="bibr">22</xref><xref rid="B49" ref-type="bibr">49</xref>]. The S19 genome sequence shows over 99.5% similarity to the genomes of strains 9&#8211;941 and 2308 [<xref rid="B30" ref-type="bibr">30</xref>].</p></sec><sec><title><italic toggle="yes">Brucella</italic> host interaction and pathogenesis</title><p>Understanding host-pathogen interactions and pathogenesis helps in developing rational vaccine designs. Like other pathogenic intracellular bacteria, <italic toggle="yes">Brucella</italic> infection requires the four following steps: adherence, invasion, establishment, and dissemination within the host [<xref rid="B58" ref-type="bibr">58</xref>]. The most striking characteristics of <italic toggle="yes">Brucella</italic> infection is that it operates in &#8220;stealth mode&#8221;, <italic toggle="yes">i.e</italic>., it can evade immune detection [<xref rid="B9" ref-type="bibr">9</xref><xref rid="B61" ref-type="bibr">61</xref>]. This mode of infection eventually leads to chronicity and prolonged infection [<xref rid="B9" ref-type="bibr">9</xref><xref rid="B31" ref-type="bibr">31</xref>]. Earlier ultrastructural work characterizing the morphology of <italic toggle="yes">B. abortus</italic>-infected cells revealed that <italic toggle="yes">Brucellae</italic> multiply in an intracellular multimembranous compartment that has similarities to the rough endoplasmic reticulum [<xref rid="B5" ref-type="bibr">5</xref>]. Weak interactions between host and <italic toggle="yes">Brucella</italic> LPS probably has a substantial role in intracellular survival [<xref rid="B17" ref-type="bibr">17</xref>]. The chronicity of brucellosis is multifactorial, utilizing both the ability of <italic toggle="yes">Brucella</italic> to evade immune detection and to adapt to intracellular survival inside both phagocytic and nonphagocytic cells [<xref rid="B31" ref-type="bibr">31</xref><xref rid="B80" ref-type="bibr">80</xref>]. The inhibition of the phagosomal-lysosomal maturation pathway and the deviation of intracellular trafficking have important roles; in this scheme, the bacterium reaches its endoplasmic reticulum-derived replicative niche [<xref rid="B20" ref-type="bibr">20</xref>].</p></sec><sec><title><italic toggle="yes">Brucella</italic> virulency with special reference to LPS</title><p>Unlike most common bacterial pathogens, <italic toggle="yes">Brucella</italic> species do not produce exotoxins, appendages such as flagella, pili, or fimbriae, antiphagocytic capsules or thick cell walls, resistant forms, and do not exhibit antigenic variation [<xref rid="B39" ref-type="bibr">39</xref>]. The success of invasion is due to the inability of the host's immune system to effectively detect or clear the bacteria, in this way the bacteria gain entry to its replicative niche and thus proliferate within professional and nonprofessional phagocytic host cells [<xref rid="B18" ref-type="bibr">18</xref><xref rid="B80" ref-type="bibr">80</xref>]. The successful evasion of host immunity is attributed to the LPS of the organism. <italic toggle="yes">Brucella</italic> possesses a peculiar nonclassical LPS that does not exhibit strong endotoxic activities similar to those of classical LPSs from enterobacteria such as <italic toggle="yes">Escherichia coli</italic> [<xref rid="B56" ref-type="bibr">56</xref>]. Further, LPS is recognized as a major virulence determinant as naturally occurring isolates lacking LPS showed reduced survival inside the host system.</p><p><italic toggle="yes">Brucella</italic> LPS is comprised of lipid A, core oligosaccharide, and O-polysaccharide (OPS). Lipid A contains 2, 3-diamino-2, 3-dideoxy-D-glucose (diaminoglucose) as backbone, amide, and ester-linked long chain saturated and hydroxylated fatty acids. The core oligosaccharide is composed of mannose, glucose, 2-amino-2, 6-dideoxy-D-glucose (quinovosamine), 2-amino-2-deoxy-D-glucose (glucosamine), 3-deoxy-D-manno-2-octulosonic acid, and unidentified sugars. The OPS is an unbranched homopolymer (n = 96&#8211;100) of 1, 2-linked 4, 6-dideoxy-4-formamido-&#945;-D-mannopyranosyl [<xref rid="B16" ref-type="bibr">16</xref><xref rid="B69" ref-type="bibr">69</xref>]. In murine macrophages, it has been demonstrated that OPS is specifically involved in inhibition of early fusion between <italic toggle="yes">Brucella suis</italic> containing-phagosomes and lysosomes In contrast, phagosomes containing rough mutants, which fail to express the O antigen, rapidly fuse with lysosomes [<xref rid="B81" ref-type="bibr">81</xref>]. Due to its central role in virulency, much research has been undertaken into the disruption of LPS biosynthesis. The aim of that research is to generate a mutant vaccine strain that has a perfect balance between attenuation and protection, and also enables differentiating infected from vaccinated animals (DIVA) [<xref rid="B54" ref-type="bibr">54</xref><xref rid="B102" ref-type="bibr">102</xref>].</p><p>Apart from the LPS involvement in virulence, the <italic toggle="yes">vir</italic>B operon, encoding a type IV secretion system homologous to those encoded by <italic toggle="yes">Agrobacterium tumefaciens vir</italic>B, and the <italic toggle="yes">Bordetella pertussis ptl</italic> operon are present in the <italic toggle="yes">Brucella</italic> genome [<xref rid="B86" ref-type="bibr">86</xref>]. The <italic toggle="yes">A. tumefaciens vir</italic>B operon encodes a pilus-like structure necessary for secretion of transfer DNA, and the <italic toggle="yes">B. pertussis ptl</italic> operon encodes an apparatus that allows the secretion of pertussis toxin, suggesting that <italic toggle="yes">Brucella</italic> may secrete regulatory DNA or protein for intracellular survival. Superoxide dismutase (SOD) forms part of the antioxidant defense system that protects bacteria from the toxic effects of reactive oxygen intermediates by converting superoxide radicals into hydrogen peroxide and oxygen [<xref rid="B40" ref-type="bibr">40</xref>], suggesting that SOD has a crucial role in <italic toggle="yes">Brucella</italic> intracellular survival. As anticipated, anti-<italic toggle="yes">Brucella</italic> SOD-based vaccines confer substantial amounts of protection [<xref rid="B23" ref-type="bibr">23</xref><xref rid="B52" ref-type="bibr">52</xref><xref rid="B93" ref-type="bibr">93</xref>].</p></sec><sec><title><italic toggle="yes">Brucella</italic> interaction with host immunity</title><p>During the initial phase of infection, approximately 90% of bacteria are killed by phagocytic cells. Dendritic cells and macrophages have important roles in clearing the infection; however, failure to lyse the organism within phagosomes leads to formation of <italic toggle="yes">Brucella</italic>-containing vacuoles and, thus, replication in this niche [<xref rid="B61" ref-type="bibr">61</xref>]. <italic toggle="yes">Brucella</italic> can also subvert the autophagy process in order to evade efficient clearing [<xref rid="B48" ref-type="bibr">48</xref><xref rid="B90" ref-type="bibr">90</xref>]. Neutrophils may have an important role in subsiding the infection via phagocytosis, as <italic toggle="yes">Brucella</italic> does not replicate within neutrophils, but it does resist neutrophil-mediated bacterial killing [<xref rid="B9" ref-type="bibr">9</xref>].</p><p>Specific antibodies have important roles in reducing the initial phase of a <italic toggle="yes">Brucella</italic> infection; however, they have limited roles following intracellular localization. Hence, strong humoral immunity unaccompanied by cell-mediated immunity (CMI) cannot provide total protection against the <italic toggle="yes">Brucella</italic> organism. B lymphocytes may act in favor of the organism by providing a replication niche [<xref rid="B43" ref-type="bibr">43</xref>] or B cells may produce interleukin (IL)-10 cytokine thereby antagonizing the production of IL-12 and interferon-&#947;, which are important for orchestrating the CMI response. It has been demonstrated that mice deficient in B cells are highly resistant to <italic toggle="yes">Brucella</italic> infection [<xref rid="B44" ref-type="bibr">44</xref>]. Several researchers have demonstrated the importance of Th1 immune response in controlling <italic toggle="yes">Brucella</italic> infection, as well as the involvement of IL-12 and INF-&#947; [<xref rid="B11" ref-type="bibr">11</xref><xref rid="B61" ref-type="bibr">61</xref>]. Hence, it is prudent to design vaccines that can augment the Th1 response while reducing the Th2 response.</p></sec></sec><sec><title>Approaches for Development of Anti-<italic toggle="yes">Brucella</italic> Vaccines</title><p>The general considerations associated with, and a summary of the different classes of, <italic toggle="yes">Brucella</italic> vaccines are listed in <xref ref-type="table" rid="T1">Table 1</xref>.</p><sec><title>Classical and commercial vaccine</title><p>The most widely used vaccine for the prevention of brucellosis in cattle is the <italic toggle="yes">B. abortus</italic> S19 vaccine, which remains the reference vaccine to which other vaccines are compared. It is used as a live vaccine and is normally given to female calves aged between 3 and 6 months as a single subcutaneous dose of 5&#8211;8 &#215; 10<sup>10</sup> viable organisms or as a reduced dose of from 3 &#215; 10<sup>8</sup> to 3 &#215; 10<sup>9</sup> organisms that can be administered subcutaneously to adult cattle. Alternatively, it can be administered to cattle of any age as either one or two doses of 5 &#215; 10<sup>9</sup> viable organisms, given via the conjunctival route [<xref rid="B50" ref-type="bibr">50</xref>]. <italic toggle="yes">B. abortus</italic> S19 has the normal properties of the biovar 1 strain of <italic toggle="yes">B. abortus</italic>, but it does not require CO<sub>2</sub> for growth, does not grow in the presence of benzylpenicillin (3 &#181;g/mL = 5 IU/mL), thionin blue (2 &#181;g/mL), or i-erythritol (1 mg/mL) (all final concentrations), and presents with high L-glutamate use [<xref rid="B50" ref-type="bibr">50</xref>].</p><p><italic toggle="yes">B. abortus</italic> strain 45/20 is a rough strain that is able to protect guinea pigs and cattle from <italic toggle="yes">Brucella</italic> infection; however, reversions to the wild smooth type has limited its use as a live vaccine [<xref rid="B62" ref-type="bibr">62</xref><xref rid="B97" ref-type="bibr">97</xref>].</p><p><italic toggle="yes">B. abortus</italic> strain RB51, a rough attenuated organism, was originally derived from a rifampicin-resistant mutant of <italic toggle="yes">B. abortus</italic> strain 2308 and has replaced <italic toggle="yes">B. abortus</italic> S19 strain as a vaccine candidate in some developed countries. Strain RB51 is very stable and has no, or highly reduced, abortifacient characteristics [<xref rid="B84" ref-type="bibr">84</xref>]. Protective efficacy and immunity induced by strain RB51 is similar to or better than that induced by strain 19 [<xref rid="B24" ref-type="bibr">24</xref><xref rid="B59" ref-type="bibr">59</xref>]. However, although strain RB51 has an excellent record of stability, it is rifampicin resistant to important antibiotics used in the treatment of brucellosis; moreover, it is still infectious to humans and the exact nature of its mutations have not been described. Recently, it was reported that RB51 vaccinated cattle in the Greater Yellowstone Area in the USA were still susceptible to brucellosis [<xref rid="B76" ref-type="bibr">76</xref><xref rid="B103" ref-type="bibr">103</xref>].</p></sec><sec><title>Genetically modified <italic toggle="yes">Brucella</italic> mutant strains</title><p>To counteract the disadvantageous properties of the smooth <italic toggle="yes">Brucella</italic> vaccines, research attention had been focused on the development of rough phenotype vaccines with greater attenuation. Rough <italic toggle="yes">Brucella</italic> mutants lack the LPS immunodominant N-formylperosamine OPS and are substantially attenuated [<xref rid="B70" ref-type="bibr">70</xref><xref rid="B85" ref-type="bibr">85</xref>]. Some rough (R) vaccines or candidates are spontaneous mutants selected after repeated passage on antibiotic-containing media. Disruption of <italic toggle="yes">per</italic>, <italic toggle="yes">pgm</italic>, <italic toggle="yes">wboA</italic>, and <italic toggle="yes">wbkA</italic> (genes involved in the LPS biosynthesis pathway) results in rough mutants [<xref rid="B67" ref-type="bibr">67</xref><xref rid="B101" ref-type="bibr">101</xref><xref rid="B108" ref-type="bibr">108</xref>], showing that empirically, R vaccines can be improved. Other notable mutants that have metabolic genes disrupted are the <italic toggle="yes">purL</italic>, <italic toggle="yes">purD</italic>, and <italic toggle="yes">purE</italic> mutants that affect the purine biosynthesis pathway genes [<xref rid="B1" ref-type="bibr">1</xref>], the lipid A fatty acid transporting gene <italic toggle="yes">bacA</italic> mutant [<xref rid="B38" ref-type="bibr">38</xref><xref rid="B57" ref-type="bibr">57</xref>], the ferrochelatase <italic toggle="yes">hemH</italic> mutant [<xref rid="B3" ref-type="bibr">3</xref>], the type IV secretion <italic toggle="yes">virB</italic> mutant [<xref rid="B34" ref-type="bibr">34</xref>], and the phosphoglycerate kinase encoding gene <italic toggle="yes">pgk</italic> mutant [<xref rid="B99" ref-type="bibr">99</xref>]. Many mutants have shown promising results by exhibiting a protection level similar to or higher than RB51. In addition, the rough strains are DIVA enabled. Despite several encouraging results, trials have not been undertaken to evaluate the protective capabilities of these mutants in the target host. Thus, conclusive data and substantial definitive host-vaccine efficacy findings have not been validated. Also due to variations in evaluation protocols, accurate comparisons between the mutants have not been possible [<xref rid="B45" ref-type="bibr">45</xref><xref rid="B110" ref-type="bibr">110</xref>].</p></sec><sec><title>Inactivated vaccines</title><sec><title>Cell fractions and lysate</title><p>Cell components from the killed organism were tested during the early development of a <italic toggle="yes">Brucella</italic> vaccine. Preparations that were evaluated included outer membrane protein [<xref rid="B68" ref-type="bibr">68</xref>], soluble and insoluble extracts of cell envelopes [<xref rid="B36" ref-type="bibr">36</xref><xref rid="B107" ref-type="bibr">107</xref>], whole killed cells [<xref rid="B10" ref-type="bibr">10</xref>], and periplasmic proteins and salt extractable proteins [<xref rid="B94" ref-type="bibr">94</xref>]. While infection-related issues were nil, several issues such as poor protection, local reactions, and serological problems hindered their popularity [<xref rid="B64" ref-type="bibr">64</xref>]. The local reactions were generally induced by adjuvants which were used to improve protective efficacy.</p></sec><sec><title>Subunit and DNA vaccine</title><p>Due to safety implications, several subunit vaccines have been evaluated. In addition, subunit vaccines have the advantage of being effective for pan-<italic toggle="yes">Brucella</italic> species because high homology protein can be selected as the candidate. Several subunit/DNA vaccine candidates have been evaluated with the central aim of evoking a Th1 response. These candidates include recombinant P39, bacterioferritin, L7/L12 [<xref rid="B2" ref-type="bibr">2</xref><xref rid="B75" ref-type="bibr">75</xref>], lumazine synthase [<xref rid="B104" ref-type="bibr">104</xref>], Bp26 and trigger factor together [<xref rid="B109" ref-type="bibr">109</xref>], InfC [<xref rid="B21" ref-type="bibr">21</xref>], L7/L12 [<xref rid="B53" ref-type="bibr">53</xref>], Omp16 and Omp19 [<xref rid="B79" ref-type="bibr">79</xref>], Omp25 [<xref rid="B27" ref-type="bibr">27</xref>], Omp28 [<xref rid="B51" ref-type="bibr">51</xref>], Omp31 [<xref rid="B19" ref-type="bibr">19</xref>], P39 [<xref rid="B2" ref-type="bibr">2</xref>], S-adenosyl-l-homocysteine hydrolase [<xref rid="B111" ref-type="bibr">111</xref>], DnaK and SurA [<xref rid="B33" ref-type="bibr">33</xref>], and SodC [<xref rid="B71" ref-type="bibr">71</xref>]. It has been demonstrated that subunit vaccines can be improved by including encapsulations such as escheriosomes and liposomes or via fortifying with IL-18 cytokines [<xref rid="B60" ref-type="bibr">60</xref><xref rid="B88" ref-type="bibr">88</xref>]. The major disadvantage of these vaccines is their relatively low protection and the requirement for several booster doses or prime boosting. Further studies are required to assess the efficacy of these candidate antigens in livestock [<xref rid="B110" ref-type="bibr">110</xref>].</p></sec><sec><title>Synthetic peptide vaccine</title><p>In 1994, Tabatabai and Pugh [<xref rid="B93" ref-type="bibr">93</xref>] synthesized three peptides derived from the primary structure of <italic toggle="yes">B. abortus</italic> Cu-Zn SOD and used those peptides in vaccines against brucellosis. Their studies showed that only peptide 3 (GGAPGEKDGKIVPAG) possessed protective biological activity, which was demonstrated by its ability to modulate both splenomegaly and the extent of <italic toggle="yes">Brucella</italic> infection in spleen [<xref rid="B91" ref-type="bibr">91</xref>]. It was concluded that peptide 3 probably contains a specific sequence preferentially recognized by the cellular immune system. Hence, this study showed that a highly selective epitope capable of activating T cells can be selected and synthesized accordingly. However, in general, this class of vaccine displays relatively low protection, which would hinder its effective deployment.</p></sec><sec><title>Vector-delivered <italic toggle="yes">Brucella</italic> vaccines</title><p>Due to its overall similarity in infection, an intracellular pathogen such as an attenuated <italic toggle="yes">Salmonella</italic> strain can be employed as a vector to deliver <italic toggle="yes">Brucella</italic> antigen at immunologically critical sites. It has been reported that oral immunization of mice with <italic toggle="yes">Salmonella</italic> expressing a 31 kDa <italic toggle="yes">Brucella</italic> protein resulted in the production of local as well as serum antibodies against the protein but resulted in poor CMI responses [<xref rid="B89" ref-type="bibr">89</xref>]. Recently, our group developed <italic toggle="yes">Salmonella</italic> Typhimurium delivery-based <italic toggle="yes">Brucella</italic> vaccines. Using a mouse model, the suitability of the vectored <italic toggle="yes">Brucella</italic> vaccine in different routes of immunization was studied [<xref rid="B52" ref-type="bibr">52</xref>]. To improve the protective efficacy, we also investigated the usefulness of these vectored vaccines when provided as a &#8220;cocktail&#8221;. The cocktail of <italic toggle="yes">Salmonella</italic> delivering heterologous antigens of <italic toggle="yes">Brucella</italic> included SOD, BLS, PrpA, and Omp19 proteins. To further improve the vaccine's efficacy, purified LPS was included in the cocktail [<xref rid="B55" ref-type="bibr">55</xref>]. Single dose immunization results were at par with the reference RB51 vaccination. Food-grade genetically modified <italic toggle="yes">Lactococcus lactis</italic> strains that express <italic toggle="yes">B. abortus</italic> GroEL heat-shock protein have been developed [<xref rid="B66" ref-type="bibr">66</xref>]; however, protective efficacies against wild-type challenges were not evaluated. It was reported that several recombinant vaccinia viruses were able to express a variety of <italic toggle="yes">Brucella</italic> antigens (HtrA, GroEL, GroES, Cu-ZnSOD, and YajC), and that study revealed that the recombinant vaccinia viruses induced specific immune responses to these antigens in mice, but the levels of protection were not significant [<xref rid="B98" ref-type="bibr">98</xref>].</p></sec></sec></sec><sec><title>Vaccine Trials for <italic toggle="yes">Brucella</italic></title><p>A general overview and summary of the different types of trial hosts are presented in <xref ref-type="table" rid="T2">Table 2</xref>.</p><sec><title>Laboratory animals</title><p>Due to economical and ethical concerns associated with experimentation in hosts such as ruminants, humans, and other primates, various small laboratory animal species serve as important tools for investigating the pathophysiology and undertaking vaccine-related trials of brucellosis [<xref rid="B46" ref-type="bibr">46</xref>]. Many foremost experiments related to <italic toggle="yes">Brucella</italic> involve the use of chicken embryo as a model [<xref rid="B15" ref-type="bibr">15</xref>]. Rabbit has mostly served as an animal for producing antibodies against <italic toggle="yes">Brucella</italic> antigens as well as a model for <italic toggle="yes">Brucella</italic> toxicity and hypersensitivity, mainly due of the susceptibility of rabbit to bacterial endotoxins and toxins [<xref rid="B4" ref-type="bibr">4</xref><xref rid="B35" ref-type="bibr">35</xref>]. However, mouse (<italic toggle="yes">Mus musculus</italic>) has been the most convenient and commonly used brucellosis model [<xref rid="B46" ref-type="bibr">46</xref><xref rid="B87" ref-type="bibr">87</xref>]. For World Organisation for Animal Health (OIE) vaccine batch potency testing and residual virulence evaluation, mice are routinely used. CD1 mice at 5 to 6 weeks of age are used for screening of candidate vaccines. Due to ease of handling, availability, and presence of large amounts of information and literature, mice are often the laboratory animal of choice [<xref rid="B46" ref-type="bibr">46</xref>]. The efficacy of a <italic toggle="yes">Brucella</italic> candidate vaccine is usually measured as a reduction in splenic colonization as compared to that in non-vaccinated but challenged controls. However, due to matching phases and pathophysiology, a guinea pig model serves as a better model than mouse for human-related anti-<italic toggle="yes">Brucella</italic> vaccine studies [<xref rid="B87" ref-type="bibr">87</xref>]. Guinea pigs exhibit similar pulmonary, hepatic, spleen, and genital lesions and have similar hypersensitivity reactions to those observed in humans; moreover, they exhibit comparative stages of infection caused by <italic toggle="yes">Brucella</italic> in natural hosts, including abortion [<xref rid="B12" ref-type="bibr">12</xref><xref rid="B13" ref-type="bibr">13</xref><xref rid="B41" ref-type="bibr">41</xref>]. In addition, guinea pigs exhibit the highest susceptibility to <italic toggle="yes">Brucella</italic> infections among the tested laboratory animals [<xref rid="B41" ref-type="bibr">41</xref>]. Hence, guinea pig represents one of the best models for several immunological and vaccine studies [<xref rid="B46" ref-type="bibr">46</xref><xref rid="B50" ref-type="bibr">50</xref><xref rid="B74" ref-type="bibr">74</xref>].</p></sec><sec><title>Livestock</title><p>Large animal experimentation and trials involving anti-<italic toggle="yes">Brucella</italic> vaccine are comparatively uncommon due to limited availability of resources. However, it is critical to characterize the equivalent immune responses in livestock hosts. Such information will provide a better understanding of the safety and efficacy of the vaccine. Brucellosis in cattle is usually caused by biovars of <italic toggle="yes">B. abortus</italic>. In some countries, particularly in southern Europe and western Asia, where cattle are kept in close association with sheep or goats, infection can also be caused by <italic toggle="yes">B. melitensis</italic>. In small ruminants, brucellosis is mainly due to <italic toggle="yes">B. melitensis</italic> [<xref rid="B42" ref-type="bibr">42</xref>]. Such brucellosis is mainly controlled by vaccination with the vaccine strain Rev. 1. This strain confers excellent immunity; however, it has two disadvantages: i) prolonged sensitization of animals resulting in interference with subsequent allergic tests; ii) formation of anti-Rev. 1 antibodies, which disappear at different rates among individual animals [<xref rid="B37" ref-type="bibr">37</xref>]. Occasionally, <italic toggle="yes">B. suis</italic> may produce a chronic infection in the mammary gland of cattle, but it has not been reported to cause abortion or spread to other animals [<xref rid="B50" ref-type="bibr">50</xref>]. Considering the disease's transmission cycle and zoonotic implications, livestock animals may be more suitably vaccinated with multivalent pan-<italic toggle="yes">Brucella</italic> species cross-protecting vaccines.</p></sec><sec><title>Companion animals</title><p><italic toggle="yes">Brucella canis</italic> is important pathogen resulting in brucellosis in dogs, and, to date, no effective anti-<italic toggle="yes">B. canis</italic> vaccine is available. Very limited research has been initiated into this type of anti-<italic toggle="yes">Brucella</italic> vaccine [<xref rid="B25" ref-type="bibr">25</xref><xref rid="B26" ref-type="bibr">26</xref><xref rid="B82" ref-type="bibr">82</xref>]. The site of injection and the type of adjuvant to be used needs to be determined before initiating vaccine trials [<xref rid="B63" ref-type="bibr">63</xref>]. Vaccines containing recombinant antigens may be less reactogenic and also less immunogenic, thus necessitating the inclusion of an adjuvant [<xref rid="B26" ref-type="bibr">26</xref>].</p></sec><sec><title>Other animals</title><p>Brucellosis has been reported in the one-humped camel (<italic toggle="yes">Camelus dromedarius</italic>), in the two-humped camel (<italic toggle="yes">Camelus bactrianus</italic>), and in South American camelids including llama (<italic toggle="yes">Lama glama</italic>), alpaca (<italic toggle="yes">Lama pacos</italic>), guanaco (<italic toggle="yes">Lama guinicoe</italic>), and vicuna (<italic toggle="yes">Vicugne vicugne</italic>). Those infections have been related to contact with large and small ruminants infected with <italic toggle="yes">B. abortus</italic> or <italic toggle="yes">B. melitensis</italic> [<xref rid="B50" ref-type="bibr">50</xref><xref rid="B106" ref-type="bibr">106</xref>]. In addition, brucellosis has been observed in the domestic buffalo (<italic toggle="yes">Bubalus bubalus</italic>), American and European bison (<italic toggle="yes">Bison bison</italic>, <italic toggle="yes">Bison bonasus</italic>), yak (<italic toggle="yes">Bos grunniens</italic>), elk/wapiti (<italic toggle="yes">Cervus elaphus</italic>), the African buffalo (<italic toggle="yes">Syncerus caffer</italic>), and various African antelope species. The clinical manifestations of brucellosis in these animals are similar to those in cattle [<xref rid="B50" ref-type="bibr">50</xref>]. However, it is uncertain whether current vaccine candidates and immunization strategies would be suitable application in feral populations of those species. Rough strain RB51 has been tested for use in wild animals, such as bison in North America, and it conferred considerable protection in test subjects; moreover, the level of protection was improved with a booster vaccine regime [<xref rid="B76" ref-type="bibr">76</xref><xref rid="B77" ref-type="bibr">77</xref>].</p></sec><sec><title>Human</title><p>To date, no vaccine licensed for human anti-<italic toggle="yes">Brucella</italic> is available. In addition, there is very little information and relevant data regarding human clinical vaccine trials. Although the threat due to bioterrorism has recently toned down [<xref rid="B47" ref-type="bibr">47</xref>], developing a safe and effective vaccine is of prime importance due to the chronic debilitating nature of brucellosis. The most extensive trial and study was held in the former Soviet Union in which over 3 million people were vaccinated with the S19 vaccine strain [<xref rid="B105" ref-type="bibr">105</xref>]. Most human brucellosis cases have been linked with infected sheep and goats [<xref rid="B28" ref-type="bibr">28</xref>]. There was a nearly 60% reduction in the number of human cases over the period 1952 to 1958. Despite conferring strong protection due to the prolonged persistency in vaccinated individuals [<xref rid="B105" ref-type="bibr">105</xref>], the deployment of S19 in humans has been limited.</p><p>Several candidate anti-<italic toggle="yes">Brucella</italic> vaccines have been proposed for the use against human brucellosis. Since <italic toggle="yes">B. melitensis</italic> is the most common species found in humans, development of a vaccine based on <italic toggle="yes">B. melitensis</italic> is prudent. Several candidate vaccines are reported to be capable of protecting against a virulent <italic toggle="yes">B. melitensis</italic> challenge in mice model [<xref rid="B7" ref-type="bibr">7</xref><xref rid="B8" ref-type="bibr">8</xref><xref rid="B95" ref-type="bibr">95</xref>]. However, validation in a primate model may be necessary prior to undertaking large scale trials. Success stories involving the control of human brucellosis via its control in an animal population have been documented in different parts of the world [<xref rid="B65" ref-type="bibr">65</xref><xref rid="B78" ref-type="bibr">78</xref>]. Nevertheless, with the increasing reports and re-emergence of brucellosis around the globe [<xref rid="B92" ref-type="bibr">92</xref><xref rid="B96" ref-type="bibr">96</xref><xref rid="B100" ref-type="bibr">100</xref>], research into developing safe, effective, cross-protecting, human exclusive vaccines must be continued.</p></sec></sec><sec sec-type="conclusions"><title>Conclusions</title><p>The most effective strategy to control human brucellosis in the absence of an appropriate human vaccine is to control brucellosis in animal populations; thereby reducing zoonotic transmission and the number of carrier hosts. For human anti-<italic toggle="yes">Brucella</italic> vaccine, safety properties should be considered of prime importance, and, ideally, the vaccine should be cross protecting. Vaccine formulation comprising a cocktail of protective antigens may be used in conjunction with an appropriate adjuvant to augment the vaccine's protective capabilities. Newer immuno-modulators such as viability-associated pathogen-associated molecular patterns may also be included in such formulations in order to mimic live bacterial infections. A major challenge in the development of an ideal vaccine lies in evoking robust CMI in the host. In general, vaccine candidates that evoke a strong CMI response confer a better level of protection. Hence, targeting the CMI branch of host immunity via induction of IL-12 and INF-&#947; should prove to be useful.</p></sec></body><back><ack><title>Acknowledgments</title><p>This research was supported by a grant from the Korea Health Technology R&amp;D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health &amp; Welfare, Korea (grant No. HI16C2130).</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Conflict of Interest:</bold> The authors declare no conflicts of interest.</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alcantara</surname><given-names>RB</given-names></name><name name-style="western"><surname>Read</surname><given-names>RD</given-names></name><name name-style="western"><surname>Valderas</surname><given-names>MW</given-names></name><name name-style="western"><surname>Brown</surname><given-names>TD</given-names></name><name name-style="western"><surname>Roop</surname><given-names>RM</given-names><suffix>2nd</suffix></name></person-group><article-title>Intact purine biosynthesis pathways are required for wild-type virulence of <italic toggle="yes">Brucella abortus</italic> 2308 in the BALB/c mouse model</article-title><source>Infect Immun</source><year>2004</year><volume>72</volume><fpage>4911</fpage><lpage>4917</lpage><pub-id pub-id-type="pmid">15271960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.72.8.4911-4917.2004</pub-id><pub-id pub-id-type="pmcid">PMC470684</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Mariri</surname><given-names>A</given-names></name><name name-style="western"><surname>Tibor</surname><given-names>A</given-names></name><name name-style="western"><surname>Mertens</surname><given-names>P</given-names></name><name name-style="western"><surname>De Bolle</surname><given-names>X</given-names></name><name name-style="western"><surname>Michel</surname><given-names>P</given-names></name><name name-style="western"><surname>Godefroid</surname><given-names>J</given-names></name><name name-style="western"><surname>Walravens</surname><given-names>K</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name></person-group><article-title>Protection of BALB/c mice against <italic toggle="yes">Brucella abortus</italic> 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant</article-title><source>Infect Immun</source><year>2001</year><volume>69</volume><fpage>4816</fpage><lpage>4822</lpage><pub-id pub-id-type="pmid">11447155</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.69.8.4816-4822.2001</pub-id><pub-id pub-id-type="pmcid">PMC98569</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Almir&#243;n</surname><given-names>M</given-names></name><name name-style="western"><surname>Mart&#237;nez</surname><given-names>M</given-names></name><name name-style="western"><surname>Sanjuan</surname><given-names>N</given-names></name><name name-style="western"><surname>Ugalde</surname><given-names>RA</given-names></name></person-group><article-title>Ferrochelatase is present in <italic toggle="yes">Brucella abortus</italic> and is critical for its intracellular survival and virulence</article-title><source>Infect Immun</source><year>2001</year><volume>69</volume><fpage>6225</fpage><lpage>6230</lpage><pub-id pub-id-type="pmid">11553564</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.69.10.6225-6230.2001</pub-id><pub-id pub-id-type="pmcid">PMC98755</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Alton</surname><given-names>GG</given-names></name><name name-style="western"><surname>Jones</surname><given-names>LM</given-names></name><name name-style="western"><surname>Angus</surname><given-names>RD</given-names></name><name name-style="western"><surname>Verger</surname><given-names>JM</given-names></name></person-group><source>Techniques for the brucellosis laboratory</source><publisher-loc>Paris</publisher-loc><publisher-name>Institut National de la Recherche Agronomique</publisher-name><year>1988</year></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>TD</given-names></name><name name-style="western"><surname>Cheville</surname><given-names>NF</given-names></name></person-group><article-title>Ultrastructural morphometric analysis of <italic toggle="yes">Brucella abortus</italic>-infected trophoblasts in experimental placentitis. Bacterial replication occurs in rough endoplasmic reticulum</article-title><source>Am J Pathol</source><year>1986</year><volume>124</volume><fpage>226</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">3090887</pub-id><pub-id pub-id-type="pmcid">PMC1888286</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="book"><collab>APPMG (All-Party Parliamentary Group on Malaria and Neglected Tropical Diseases)</collab><source>The Neglected Tropical Diseases: A Challenge We Could Rise to -- Will We?</source><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><year>2009</year></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arenas-Gamboa</surname><given-names>AM</given-names></name><name name-style="western"><surname>Ficht</surname><given-names>TA</given-names></name><name name-style="western"><surname>Kahl-McDonagh</surname><given-names>MM</given-names></name><name name-style="western"><surname>Rice-Ficht</surname><given-names>AC</given-names></name></person-group><article-title>Immunization with a single dose of a microencapsulated <italic toggle="yes">Brucella melitensis</italic> mutant enhances protection against wild-type challenge</article-title><source>Infect Immun</source><year>2008</year><volume>76</volume><fpage>2448</fpage><lpage>2455</lpage><pub-id pub-id-type="pmid">18362129</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.00767-07</pub-id><pub-id pub-id-type="pmcid">PMC2423109</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arenas-Gamboa</surname><given-names>AM</given-names></name><name name-style="western"><surname>Rice-Ficht</surname><given-names>AC</given-names></name><name name-style="western"><surname>Kahl-McDonagh</surname><given-names>MM</given-names></name><name name-style="western"><surname>Ficht</surname><given-names>TA</given-names></name></person-group><article-title>Protective efficacy and safety of <italic toggle="yes">Brucella melitensis</italic> 16M&#916;<italic toggle="yes">mucR</italic> against intraperitoneal and aerosol challenge in BALB/c mice</article-title><source>Infect Immun</source><year>2011</year><volume>79</volume><fpage>3653</fpage><lpage>3658</lpage><pub-id pub-id-type="pmid">21708998</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.05330-11</pub-id><pub-id pub-id-type="pmcid">PMC3165458</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barquero-Calvo</surname><given-names>E</given-names></name><name name-style="western"><surname>Chaves-Olarte</surname><given-names>E</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>DS</given-names></name><name name-style="western"><surname>Guzm&#225;n-Verri</surname><given-names>C</given-names></name><name name-style="western"><surname>Chac&#243;n-D&#237;az</surname><given-names>C</given-names></name><name name-style="western"><surname>Rucavado</surname><given-names>A</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name></person-group><article-title><italic toggle="yes">Brucella abortus</italic> uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection</article-title><source>PLoS One</source><year>2007</year><volume>2</volume><fpage>e631</fpage><pub-id pub-id-type="pmid">17637846</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0000631</pub-id><pub-id pub-id-type="pmcid">PMC1910614</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gamazo</surname><given-names>C</given-names></name><name name-style="western"><surname>Winter</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Jim&#233;nez de Bag&#252;&#233;s</surname><given-names>MP</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C</given-names></name><name name-style="western"><surname>Barber&#225;n</surname><given-names>M</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Alonso-Urmeneta</surname><given-names>B</given-names></name><name name-style="western"><surname>D&#237;az</surname><given-names>R</given-names></name></person-group><article-title>Evaluation of whole cell and subcellular vaccines against <italic toggle="yes">Brucella ovis</italic> in rams</article-title><source>Vet Immunol Immunopathol</source><year>1993</year><volume>37</volume><fpage>257</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">8236802</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0165-2427(93)90198-d</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brand&#227;o</surname><given-names>AP</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>FS</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>NB</given-names></name><name name-style="western"><surname>Vieira</surname><given-names>LQ</given-names></name><name name-style="western"><surname>Azevedo</surname><given-names>V</given-names></name><name name-style="western"><surname>Macedo</surname><given-names>GC</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>SC</given-names></name></person-group><article-title>Host susceptibility to <italic toggle="yes">Brucella abortus</italic> infection is more pronounced in IFN-&#947; knockout than IL-12/&#946;2-microglobulin double-deficient mice</article-title><source>Clin Dev Immunol</source><year>2012</year><volume>2012</volume><fpage>589494</fpage><pub-id pub-id-type="pmid">22194770</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2012/589494</pub-id><pub-id pub-id-type="pmcid">PMC3238360</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braude</surname><given-names>AI</given-names></name></person-group><article-title>Studies in the pathology and pathogenesis of experimental brucellosis. II. The formation of the hepatic granuloma and its evolution</article-title><source>J Infect Dis</source><year>1951</year><volume>89</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">14861465</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/89.1.87</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braude</surname><given-names>AI</given-names></name><name name-style="western"><surname>Spink</surname><given-names>WW</given-names></name></person-group><article-title>Studies in the pathology and pathogenesis of experimental brucellosis. III. Investigations pertaining to the function of the spleen</article-title><source>J Infect Dis</source><year>1951</year><volume>89</volume><fpage>272</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">14888952</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/89.3.272</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruce</surname><given-names>D</given-names></name></person-group><article-title>Note on the discovery of a microorganism in Malta fever</article-title><source>Practitioner</source><year>1887</year><volume>39</volume><fpage>161</fpage><lpage>170</lpage></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buddingh</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Womack</surname><given-names>FC</given-names><suffix>Jr</suffix></name></person-group><article-title>Observations on the infection of chick embryos with <italic toggle="yes">Bacterium tularense</italic>, <italic toggle="yes">Brucella</italic>, and <italic toggle="yes">Pasteurella pestis</italic></article-title><source>J Exp Med</source><year>1941</year><volume>74</volume><fpage>213</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">19871129</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.74.3.213</pub-id><pub-id pub-id-type="pmcid">PMC2135183</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bundle</surname><given-names>DR</given-names></name><name name-style="western"><surname>Cherwonogrodzky</surname><given-names>JW</given-names></name><name name-style="western"><surname>Gidney</surname><given-names>MA</given-names></name><name name-style="western"><surname>Meikle</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Perry</surname><given-names>MB</given-names></name><name name-style="western"><surname>Peters</surname><given-names>T</given-names></name></person-group><article-title>Definition of <italic toggle="yes">Brucella</italic> A and M epitopes by monoclonal typing reagents and synthetic oligosaccharides</article-title><source>Infect Immun</source><year>1989</year><volume>57</volume><fpage>2829</fpage><lpage>2836</lpage><pub-id pub-id-type="pmid">2474505</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.57.9.2829-2836.1989</pub-id><pub-id pub-id-type="pmcid">PMC313534</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Canning</surname><given-names>PC</given-names></name><name name-style="western"><surname>Roth</surname><given-names>JA</given-names></name><name name-style="western"><surname>Deyoe</surname><given-names>BL</given-names></name></person-group><article-title>Release of 5'-guanosine monophosphate and adenine by <italic toggle="yes">Brucella abortus</italic> and their role in the intracellular survival of the bacteria</article-title><source>J Infect Dis</source><year>1986</year><volume>154</volume><fpage>464</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">3016113</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/154.3.464</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cardoso</surname><given-names>PG</given-names></name><name name-style="western"><surname>Macedo</surname><given-names>GC</given-names></name><name name-style="western"><surname>Azevedo</surname><given-names>V</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>SC</given-names></name></person-group><article-title><italic toggle="yes">Brucella</italic> spp noncanonical LPS: structure, biosynthesis, and interaction with host immune system</article-title><source>Microb Cell Fact</source><year>2006</year><volume>5</volume><fpage>13</fpage><pub-id pub-id-type="pmid">16556309</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1475-2859-5-13</pub-id><pub-id pub-id-type="pmcid">PMC1435926</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name><name name-style="western"><surname>Velikovsky</surname><given-names>CA</given-names></name><name name-style="western"><surname>de la Barrera</surname><given-names>S</given-names></name><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>L</given-names></name><name name-style="western"><surname>Bowden</surname><given-names>R</given-names></name><name name-style="western"><surname>Pasquevich</surname><given-names>KA</given-names></name><name name-style="western"><surname>Fossati</surname><given-names>CA</given-names></name><name name-style="western"><surname>Giambartolomei</surname><given-names>GH</given-names></name></person-group><article-title>A DNA vaccine coding for the <italic toggle="yes">Brucella</italic> outer membrane protein 31 confers protection against <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. ovis</italic> infection by eliciting a specific cytotoxic response</article-title><source>Infect Immun</source><year>2005</year><volume>73</volume><fpage>6537</fpage><lpage>6546</lpage><pub-id pub-id-type="pmid">16177328</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.73.10.6537-6546.2005</pub-id><pub-id pub-id-type="pmcid">PMC1230944</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Celli</surname><given-names>J</given-names></name><name name-style="western"><surname>de Chastellier</surname><given-names>C</given-names></name><name name-style="western"><surname>Franchini</surname><given-names>DM</given-names></name><name name-style="western"><surname>Pizarro-Cerda</surname><given-names>J</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name></person-group><article-title><italic toggle="yes">Brucella</italic> evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum</article-title><source>J Exp Med</source><year>2003</year><volume>198</volume><fpage>545</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">12925673</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20030088</pub-id><pub-id pub-id-type="pmcid">PMC2194179</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cespedes</surname><given-names>S</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>E</given-names></name><name name-style="western"><surname>Folch</surname><given-names>H</given-names></name><name name-style="western"><surname>O&#241;ate</surname><given-names>A</given-names></name></person-group><article-title>Identification and partial characterisation of a new protective antigen of <italic toggle="yes">Brucella abortus</italic></article-title><source>J Med Microbiol</source><year>2000</year><volume>49</volume><fpage>165</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">10670567</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1099/0022-1317-49-2-165</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chain</surname><given-names>PS</given-names></name><name name-style="western"><surname>Comerci</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Tolmasky</surname><given-names>ME</given-names></name><name name-style="western"><surname>Larimer</surname><given-names>FW</given-names></name><name name-style="western"><surname>Malfatti</surname><given-names>SA</given-names></name><name name-style="western"><surname>Vergez</surname><given-names>LM</given-names></name><name name-style="western"><surname>Aguero</surname><given-names>F</given-names></name><name name-style="western"><surname>Land</surname><given-names>ML</given-names></name><name name-style="western"><surname>Ugalde</surname><given-names>RA</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>E</given-names></name></person-group><article-title>Whole-genome analyses of speciation events in pathogenic Brucellae</article-title><source>Infect Immun</source><year>2005</year><volume>73</volume><fpage>8353</fpage><lpage>8361</lpage><pub-id pub-id-type="pmid">16299333</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.73.12.8353-8361.2005</pub-id><pub-id pub-id-type="pmcid">PMC1307078</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaudhuri</surname><given-names>P</given-names></name><name name-style="western"><surname>Singha</surname><given-names>H</given-names></name><name name-style="western"><surname>Goswami</surname><given-names>TK</given-names></name><name name-style="western"><surname>Jana</surname><given-names>C</given-names></name><name name-style="western"><surname>Shukla</surname><given-names>G</given-names></name></person-group><article-title>DNA prime and protein boost immunization with combined SOD-L7/L12 antigen confers protection to mice against <italic toggle="yes">Brucella abortus</italic> 544 challenge</article-title><source>Adv Anim Vet Sci</source><year>2013</year><volume>1</volume><fpage>143</fpage><lpage>147</lpage></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheville</surname><given-names>NF</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>AE</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>MG</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>MV</given-names></name><name name-style="western"><surname>Florance</surname><given-names>AM</given-names></name></person-group><article-title>Effects of age at vaccination on efficacy of <italic toggle="yes">Brucella abortus</italic> strain RB51 to protect cattle against brucellosis</article-title><source>Am J Vet Res</source><year>1996</year><volume>57</volume><fpage>1153</fpage><lpage>1156</lpage><pub-id pub-id-type="pmid">8836366</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clausse</surname><given-names>M</given-names></name><name name-style="western"><surname>D&#237;az</surname><given-names>AG</given-names></name><name name-style="western"><surname>Ghersi</surname><given-names>G</given-names></name><name name-style="western"><surname>Zylberman</surname><given-names>V</given-names></name><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name><name name-style="western"><surname>Giambartolomei</surname><given-names>GH</given-names></name><name name-style="western"><surname>Goldbaum</surname><given-names>FA</given-names></name><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name></person-group><article-title>The vaccine candidate BLSOmp31 protects mice against <italic toggle="yes">Brucella canis</italic> infection</article-title><source>Vaccine</source><year>2013</year><volume>31</volume><fpage>6129</fpage><lpage>6135</lpage><pub-id pub-id-type="pmid">23906889</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2013.07.041</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clausse</surname><given-names>M</given-names></name><name name-style="western"><surname>D&#237;az</surname><given-names>AG</given-names></name><name name-style="western"><surname>Iba&#241;ez</surname><given-names>AE</given-names></name><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name><name name-style="western"><surname>Giambartolomei</surname><given-names>GH</given-names></name><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name></person-group><article-title>Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against <italic toggle="yes">Brucella canis</italic> in BALB/c mice</article-title><source>Clin Vaccine Immunol</source><year>2014</year><volume>21</volume><fpage>1689</fpage><lpage>1694</lpage><pub-id pub-id-type="pmid">25339409</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CVI.00527-14</pub-id><pub-id pub-id-type="pmcid">PMC4248782</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Commander</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Spencer</surname><given-names>SA</given-names></name><name name-style="western"><surname>Wren</surname><given-names>BW</given-names></name><name name-style="western"><surname>MacMillan</surname><given-names>AP</given-names></name></person-group><article-title>The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding <italic toggle="yes">Brucella melitensis</italic> 16M genes</article-title><source>Vaccine</source><year>2007</year><volume>25</volume><fpage>43</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">17049676</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2006.07.046</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corbel</surname><given-names>MJ</given-names></name></person-group><article-title>Brucellosis: an overview</article-title><source>Emerg Infect Dis</source><year>1997</year><volume>3</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">9204307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3201/eid0302.970219</pub-id><pub-id pub-id-type="pmcid">PMC2627605</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Corbel</surname><given-names>MJ</given-names></name></person-group><source>Brucellosis in humans and animals</source><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><year>2006</year></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crasta</surname><given-names>OR</given-names></name><name name-style="western"><surname>Folkerts</surname><given-names>O</given-names></name><name name-style="western"><surname>Fei</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mane</surname><given-names>SP</given-names></name><name name-style="western"><surname>Evans</surname><given-names>C</given-names></name><name name-style="western"><surname>Martino-Catt</surname><given-names>S</given-names></name><name name-style="western"><surname>Bricker</surname><given-names>B</given-names></name><name name-style="western"><surname>Yu</surname><given-names>G</given-names></name><name name-style="western"><surname>Du</surname><given-names>L</given-names></name><name name-style="western"><surname>Sobral</surname><given-names>BW</given-names></name></person-group><article-title>Genome sequence of <italic toggle="yes">Brucella abortus</italic> vaccine strain S19 compared to virulent strains yields candidate virulence genes</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e2193</fpage><pub-id pub-id-type="pmid">18478107</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0002193</pub-id><pub-id pub-id-type="pmcid">PMC2364660</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Figueiredo</surname><given-names>P</given-names></name><name name-style="western"><surname>Ficht</surname><given-names>TA</given-names></name><name name-style="western"><surname>Rice-Ficht</surname><given-names>A</given-names></name><name name-style="western"><surname>Rossetti</surname><given-names>CA</given-names></name><name name-style="western"><surname>Adams</surname><given-names>LG</given-names></name></person-group><article-title>Pathogenesis and immunobiology of brucellosis: review of <italic toggle="yes">Brucella</italic>-host interactions</article-title><source>Am J Pathol</source><year>2015</year><volume>185</volume><fpage>1505</fpage><lpage>1517</lpage><pub-id pub-id-type="pmid">25892682</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajpath.2015.03.003</pub-id><pub-id pub-id-type="pmcid">PMC4450313</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Ley</surname><given-names>J</given-names></name><name name-style="western"><surname>Mannheim</surname><given-names>W</given-names></name><name name-style="western"><surname>Segers</surname><given-names>P</given-names></name><name name-style="western"><surname>Lievens</surname><given-names>A</given-names></name><name name-style="western"><surname>Denijn</surname><given-names>M</given-names></name><name name-style="western"><surname>Vanhoucke</surname><given-names>M</given-names></name><name name-style="western"><surname>Gillis</surname><given-names>M</given-names></name></person-group><article-title>Ribosomal ribonucleic acid cistron similarities and taxonomic neighborhood of <italic toggle="yes">Brucella</italic> and CDC group Vd</article-title><source>Int J Syst Bacteriol</source><year>1987</year><volume>37</volume><fpage>35</fpage><lpage>42</lpage></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delpino</surname><given-names>MV</given-names></name><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name><name name-style="western"><surname>Fossati</surname><given-names>CA</given-names></name><name name-style="western"><surname>Baldi</surname><given-names>PC</given-names></name><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name></person-group><article-title>Vaccination with <italic toggle="yes">Brucella</italic> recombinant DnaK and SurA proteins induces protection against <italic toggle="yes">Brucella abortus</italic> infection in BALB/c mice</article-title><source>Vaccine</source><year>2007</year><volume>25</volume><fpage>6721</fpage><lpage>6729</lpage><pub-id pub-id-type="pmid">17686554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2007.07.002</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>den Hartigh</surname><given-names>AB</given-names></name><name name-style="western"><surname>Sun</surname><given-names>YH</given-names></name><name name-style="western"><surname>Sondervan</surname><given-names>D</given-names></name><name name-style="western"><surname>Heuvelmans</surname><given-names>N</given-names></name><name name-style="western"><surname>Reinders</surname><given-names>MO</given-names></name><name name-style="western"><surname>Ficht</surname><given-names>TA</given-names></name><name name-style="western"><surname>Tsolis</surname><given-names>RM</given-names></name></person-group><article-title>Differential requirements for VirB1 and VirB2 during <italic toggle="yes">Brucella abortus</italic> infection</article-title><source>Infect Immun</source><year>2004</year><volume>72</volume><fpage>5143</fpage><lpage>5149</lpage><pub-id pub-id-type="pmid">15322008</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.72.9.5143-5149.2004</pub-id><pub-id pub-id-type="pmcid">PMC517456</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diaz</surname><given-names>R</given-names></name><name name-style="western"><surname>Oyeledun</surname><given-names>MA</given-names></name></person-group><article-title>Studies of some biological activities of &#8220;brucella&#8221; endotoxin in normal and infected animals and the role of the hypersensitivity factor</article-title><source>Ann Sclavo</source><year>1977</year><volume>19</volume><fpage>117</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">907380</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dzata</surname><given-names>GK</given-names></name><name name-style="western"><surname>Confer</surname><given-names>AW</given-names></name><name name-style="western"><surname>Wyckoff</surname><given-names>JH</given-names><suffix>3rd</suffix></name></person-group><article-title>The effects of adjuvants on immune responses in cattle injected with a <italic toggle="yes">Brucella abortus</italic> soluble antigen</article-title><source>Vet Microbiol</source><year>1991</year><volume>29</volume><fpage>27</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">1835213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0378-1135(91)90108-r</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fensterbank</surname><given-names>R</given-names></name></person-group><article-title>Brucellosis in cattle, sheep and goats: diagnosis, control and vaccination</article-title><source>Rev Sci Tech Off Int Epiz</source><year>1986</year><volume>5</volume><fpage>605</fpage><lpage>618</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.20506/rst.5.3.269</pub-id><pub-id pub-id-type="pmid">32736440</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferguson</surname><given-names>GP</given-names></name><name name-style="western"><surname>Datta</surname><given-names>A</given-names></name><name name-style="western"><surname>Baumgartner</surname><given-names>J</given-names></name><name name-style="western"><surname>Roop</surname><given-names>RM</given-names><suffix>2nd</suffix></name><name name-style="western"><surname>Carlson</surname><given-names>RW</given-names></name><name name-style="western"><surname>Walker</surname><given-names>GC</given-names></name></person-group><article-title>Similarity to peroxisomal-membrane protein family reveals that <italic toggle="yes">Sinorhizobium</italic> and <italic toggle="yes">Brucella</italic> BacA affect lipid-A fatty acids</article-title><source>Proc Natl Acad Sci U S A</source><year>2004</year><volume>101</volume><fpage>5012</fpage><lpage>5017</lpage><pub-id pub-id-type="pmid">15044696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0307137101</pub-id><pub-id pub-id-type="pmcid">PMC387365</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finlay</surname><given-names>BB</given-names></name><name name-style="western"><surname>Falkow</surname><given-names>S</given-names></name></person-group><article-title>Common themes in microbial pathogenicity</article-title><source>Microbiol Rev</source><year>1989</year><volume>53</volume><fpage>210</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">2569162</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mr.53.2.210-230.1989</pub-id><pub-id pub-id-type="pmcid">PMC372728</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fridovich</surname><given-names>I</given-names></name></person-group><article-title>Superoxide dismutases. An adaptation to a paramagnetic gas</article-title><source>J Biol Chem</source><year>1989</year><volume>264</volume><fpage>7761</fpage><lpage>7764</lpage><pub-id pub-id-type="pmid">2542241</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Garc&#237;a-Carrillo</surname><given-names>C</given-names></name></person-group><chapter-title>Laboratory animal models for brucellosis studies</chapter-title><person-group person-group-type="editor"><name name-style="western"><surname>Nielsen</surname><given-names>K</given-names></name><name name-style="western"><surname>Duncan</surname><suffix>JR</suffix></name></person-group><source>Animal Brucellosis</source><publisher-loc>Boca Raton</publisher-loc><publisher-name>CRC Press</publisher-name><year>1990</year><fpage>423</fpage><lpage>442</lpage></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Grayon</surname><given-names>M</given-names></name><name name-style="western"><surname>Verger</surname><given-names>JM</given-names></name></person-group><article-title>Brucella melitensis infection in sheep: present and future</article-title><source>Vet Res</source><year>1998</year><volume>29</volume><fpage>255</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">9689741</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goenka</surname><given-names>R</given-names></name><name name-style="western"><surname>Guirnalda</surname><given-names>PD</given-names></name><name name-style="western"><surname>Black</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Baldwin</surname><given-names>CL</given-names></name></person-group><article-title>B lymphocytes provide an infection niche for intracellular bacterium <italic toggle="yes">Brucella abortus</italic></article-title><source>J Infect Dis</source><year>2012</year><volume>206</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">22561364</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jis310</pub-id><pub-id pub-id-type="pmcid">PMC3415929</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goenka</surname><given-names>R</given-names></name><name name-style="western"><surname>Parent</surname><given-names>MA</given-names></name><name name-style="western"><surname>Elzer</surname><given-names>PH</given-names></name><name name-style="western"><surname>Baldwin</surname><given-names>CL</given-names></name></person-group><article-title>B cell-deficient mice display markedly enhanced resistance to the intracellular bacterium <italic toggle="yes">Brucella abortus</italic></article-title><source>J Infect Dis</source><year>2011</year><volume>203</volume><fpage>1136</fpage><lpage>1146</lpage><pub-id pub-id-type="pmid">21451002</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jiq171</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Ali</surname><given-names>T</given-names></name><name name-style="western"><surname>Arce-Gorvel</surname><given-names>V</given-names></name><name name-style="western"><surname>Delrue</surname><given-names>RM</given-names></name><name name-style="western"><surname>Conde-Alvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>P</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Weintraub</surname><given-names>A</given-names></name><name name-style="western"><surname>Widmalm</surname><given-names>G</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>M</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name></person-group><article-title>Brucellosis vaccines: assessment of <italic toggle="yes">Brucella melitensis</italic> lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e2760</fpage><pub-id pub-id-type="pmid">18648644</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0002760</pub-id><pub-id pub-id-type="pmcid">PMC2453230</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name></person-group><article-title>What have we learned from brucellosis in the mouse model?</article-title><source>Vet Res</source><year>2012</year><volume>43</volume><fpage>29</fpage><pub-id pub-id-type="pmid">22500859</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1297-9716-43-29</pub-id><pub-id pub-id-type="pmcid">PMC3410789</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guihot</surname><given-names>A</given-names></name><name name-style="western"><surname>Bossi</surname><given-names>P</given-names></name><name name-style="western"><surname>Bricaire</surname><given-names>F</given-names></name></person-group><article-title>[Bioterrorism with brucellosis]</article-title><source>Presse Med</source><year>2004</year><volume>33</volume><fpage>119</fpage><lpage>122</lpage><comment>French</comment><pub-id pub-id-type="pmid">15026707</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0755-4982(04)98500-4</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Hu</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>J</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>K</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Du</surname><given-names>G</given-names></name></person-group><article-title>Autophagy favors <italic toggle="yes">Brucella melitensis</italic> survival in infected macrophages</article-title><source>Cell Mol Biol Lett</source><year>2012</year><volume>17</volume><fpage>249</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">22367856</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2478/s11658-012-0009-4</pub-id><pub-id pub-id-type="pmcid">PMC6275789</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halling</surname><given-names>SM</given-names></name><name name-style="western"><surname>Peterson-Burch</surname><given-names>BD</given-names></name><name name-style="western"><surname>Bricker</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Zuerner</surname><given-names>RL</given-names></name><name name-style="western"><surname>Qing</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>LL</given-names></name><name name-style="western"><surname>Kapur</surname><given-names>V</given-names></name><name name-style="western"><surname>Alt</surname><given-names>DP</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name></person-group><article-title>Completion of the genome sequence of <italic toggle="yes">Brucella abortus</italic> and comparison to the highly similar genomes of <italic toggle="yes">Brucella melitensis</italic> and <italic toggle="yes">Brucella suis</italic></article-title><source>J Bacteriol</source><year>2005</year><volume>187</volume><fpage>2715</fpage><lpage>2726</lpage><pub-id pub-id-type="pmid">15805518</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JB.187.8.2715-2726.2005</pub-id><pub-id pub-id-type="pmcid">PMC1070361</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="book"><collab>International Office of Epizootics</collab><chapter-title>Bovine brucellosis</chapter-title><collab collab-type="editors">International Office of Epizootics</collab><source>Manual of Diagnostic Tests and Vaccines for Terrestrial Animals: Mammals, Birds and Bees</source><edition>7th ed</edition><publisher-loc>Paris</publisher-loc><publisher-name>World Organisation for Animal Health (OIE)</publisher-name><year>2009</year><fpage>1</fpage><lpage>35</lpage></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaushik</surname><given-names>P</given-names></name><name name-style="western"><surname>Singh</surname><given-names>DK</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>SV</given-names></name><name name-style="western"><surname>Tiwari</surname><given-names>AK</given-names></name><name name-style="western"><surname>Shukla</surname><given-names>G</given-names></name><name name-style="western"><surname>Dayal</surname><given-names>S</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>P</given-names></name></person-group><article-title>Protection of mice against <italic toggle="yes">Brucella abortus</italic> 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides</article-title><source>Vet Res Commun</source><year>2010</year><volume>34</volume><fpage>119</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">20013309</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11259-009-9337-x</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>WK</given-names></name><name name-style="western"><surname>Moon</surname><given-names>JY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S</given-names></name><name name-style="western"><surname>Hur</surname><given-names>J</given-names></name></person-group><article-title>Comparison between immunization routes of live attenuated <italic toggle="yes">Salmonella</italic> Typhimurium strains expressing BCSP31, Omp3b, and SOD of <italic toggle="yes">Brucella abortus</italic> in murine model</article-title><source>Front Microbiol</source><year>2016</year><volume>7</volume><fpage>550</fpage><pub-id pub-id-type="pmid">27148232</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2016.00550</pub-id><pub-id pub-id-type="pmcid">PMC4837157</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurar</surname><given-names>E</given-names></name><name name-style="western"><surname>Splitter</surname><given-names>GA</given-names></name></person-group><article-title>Nucleic acid vaccination of <italic toggle="yes">Brucella abortus</italic> ribosomal L7/L12 gene elicits immune response</article-title><source>Vaccine</source><year>1997</year><volume>15</volume><fpage>1851</fpage><lpage>1857</lpage><pub-id pub-id-type="pmid">9413093</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0264-410x(97)00140-0</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lalsiamthara</surname><given-names>J</given-names></name><name name-style="western"><surname>Gogia</surname><given-names>N</given-names></name><name name-style="western"><surname>Goswami</surname><given-names>TK</given-names></name><name name-style="western"><surname>Singh</surname><given-names>RK</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>P</given-names></name></person-group><article-title>Intermediate rough <italic toggle="yes">Brucella abortus</italic> S19&#916;<italic toggle="yes">per</italic> mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice</article-title><source>Vaccine</source><year>2015</year><volume>33</volume><fpage>2577</fpage><lpage>2583</lpage><pub-id pub-id-type="pmid">25869887</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2015.04.004</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lalsiamthara</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name></person-group><article-title><italic toggle="yes">Brucella</italic> lipopolysaccharide reinforced <italic toggle="yes">Salmonella</italic> delivering <italic toggle="yes">Brucella</italic> immunogens protects mice against virulent challenge</article-title><source>Vet Microbiol</source><year>2017</year><volume>205</volume><fpage>84</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">28622869</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vetmic.2017.05.012</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lapaque</surname><given-names>N</given-names></name><name name-style="western"><surname>Moriyon</surname><given-names>I</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name></person-group><article-title><italic toggle="yes">Brucella</italic> lipopolysaccharide acts as a virulence factor</article-title><source>Curr Opin Microbiol</source><year>2005</year><volume>8</volume><fpage>60</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">15694858</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mib.2004.12.003</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LeVier</surname><given-names>K</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>RW</given-names></name><name name-style="western"><surname>Grippe</surname><given-names>VK</given-names></name><name name-style="western"><surname>Roop</surname><given-names>RM</given-names><suffix>2nd</suffix></name><name name-style="western"><surname>Walker</surname><given-names>GC</given-names></name></person-group><article-title>Similar requirements of a plant symbiont and a mammalian pathogen for prolonged intracellular survival</article-title><source>Science</source><year>2000</year><volume>287</volume><fpage>2492</fpage><lpage>2493</lpage><pub-id pub-id-type="pmid">10741969</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.287.5462.2492</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liautard</surname><given-names>JP</given-names></name><name name-style="western"><surname>Gross</surname><given-names>A</given-names></name><name name-style="western"><surname>Dornand</surname><given-names>J</given-names></name><name name-style="western"><surname>K&#246;hler</surname><given-names>S</given-names></name></person-group><article-title>Interactions between professional phagocytes and <italic toggle="yes">Brucella</italic> spp</article-title><source>Microbiologia</source><year>1996</year><volume>12</volume><fpage>197</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">8767704</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lord</surname><given-names>VR</given-names></name><name name-style="western"><surname>Schurig</surname><given-names>GG</given-names></name><name name-style="western"><surname>Cherwonogrodzky</surname><given-names>JW</given-names></name><name name-style="western"><surname>Marcano</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Melendez</surname><given-names>GE</given-names></name></person-group><article-title>Field study of vaccination of cattle with <italic toggle="yes">Brucella abortus</italic> strains RB51 and 19 under high and low disease prevalence</article-title><source>Am J Vet Res</source><year>1998</year><volume>59</volume><fpage>1016</fpage><lpage>1020</lpage><pub-id pub-id-type="pmid">9706206</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mallick</surname><given-names>AI</given-names></name><name name-style="western"><surname>Singha</surname><given-names>H</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>P</given-names></name><name name-style="western"><surname>Nadeem</surname><given-names>A</given-names></name><name name-style="western"><surname>Khan</surname><given-names>SA</given-names></name><name name-style="western"><surname>Dar</surname><given-names>KA</given-names></name><name name-style="western"><surname>Owais</surname><given-names>M</given-names></name></person-group><article-title>Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against <italic toggle="yes">Brucella abortus</italic> 544 infection</article-title><source>Vaccine</source><year>2007</year><volume>25</volume><fpage>3692</fpage><lpage>3704</lpage><pub-id pub-id-type="pmid">17296251</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2007.01.066</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martirosyan</surname><given-names>A</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name></person-group><article-title>An evolutionary strategy for a stealthy intracellular <italic toggle="yes">Brucella</italic> pathogen</article-title><source>Immunol Rev</source><year>2011</year><volume>240</volume><fpage>211</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">21349096</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-065X.2010.00982.x</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McEwen</surname><given-names>AD</given-names></name></person-group><article-title>Experiments on contagious abortion. The immunity of cattle inoculated with vaccines of grades virulence</article-title><source>Vet Rec</source><year>1940</year><volume>52</volume><fpage>815</fpage><lpage>819</lpage></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meeusen</surname><given-names>EN</given-names></name><name name-style="western"><surname>Walker</surname><given-names>J</given-names></name><name name-style="western"><surname>Peters</surname><given-names>A</given-names></name><name name-style="western"><surname>Pastoret</surname><given-names>PP</given-names></name><name name-style="western"><surname>Jungersen</surname><given-names>G</given-names></name></person-group><article-title>Current status of veterinary vaccines</article-title><source>Clin Microbiol Rev</source><year>2007</year><volume>20</volume><fpage>489</fpage><lpage>510</lpage><pub-id pub-id-type="pmid">17630337</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CMR.00005-07</pub-id><pub-id pub-id-type="pmcid">PMC1932753</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meyer</surname><given-names>ME</given-names></name><name name-style="western"><surname>Gibbons</surname><given-names>RW</given-names></name></person-group><article-title>Results of trial use of H-38 vaccine for immunizing beef heifers against experimental exposure to <italic toggle="yes">Brucella abortus</italic>, strain 2308</article-title><source>Proc Annu Meet U S Anim Health Assoc</source><year>1978</year><issue>82</issue><fpage>106</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">109844</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minas</surname><given-names>A</given-names></name><name name-style="western"><surname>Minas</surname><given-names>M</given-names></name><name name-style="western"><surname>Stournara</surname><given-names>A</given-names></name><name name-style="western"><surname>Tselepidis</surname><given-names>S</given-names></name></person-group><article-title>The &#8220;effects&#8221; of Rev-1 vaccination of sheep and goats on human brucellosis in Greece</article-title><source>Prev Vet Med</source><year>2004</year><volume>64</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">15219968</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.prevetmed.2004.03.007</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyoshi</surname><given-names>A</given-names></name><name name-style="western"><surname>Berm&#250;dez-Humar&#225;n</surname><given-names>LG</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>LA</given-names></name><name name-style="western"><surname>Le Loir</surname><given-names>Y</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>SC</given-names></name><name name-style="western"><surname>Langella</surname><given-names>P</given-names></name><name name-style="western"><surname>Azevedo</surname><given-names>V</given-names></name></person-group><article-title>Heterologous expression of <italic toggle="yes">Brucella abortus</italic> GroEL heat-shock protein in <italic toggle="yes">Lactococcus lactis</italic></article-title><source>Microb Cell Fact</source><year>2006</year><volume>5</volume><fpage>14</fpage><pub-id pub-id-type="pmid">16556312</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1475-2859-5-14</pub-id><pub-id pub-id-type="pmcid">PMC1444932</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monreal</surname><given-names>D</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name></person-group><article-title>Characterization of <italic toggle="yes">Brucella abortus</italic> O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against <italic toggle="yes">Brucella abortus</italic> and <italic toggle="yes">Brucella ovis</italic> in the mouse model</article-title><source>Infect Immun</source><year>2003</year><volume>71</volume><fpage>3261</fpage><lpage>3271</lpage><pub-id pub-id-type="pmid">12761107</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.71.6.3261-3271.2003</pub-id><pub-id pub-id-type="pmcid">PMC155776</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montaraz</surname><given-names>JA</given-names></name><name name-style="western"><surname>Winter</surname><given-names>AJ</given-names></name></person-group><article-title>Comparison of living and nonliving vaccines for <italic toggle="yes">Brucella abortus</italic> in BALB/c mice</article-title><source>Infect Immun</source><year>1986</year><volume>53</volume><fpage>245</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">3089933</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.53.2.245-251.1986</pub-id><pub-id pub-id-type="pmcid">PMC260865</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Stackebrandt</surname><given-names>E</given-names></name><name name-style="western"><surname>Dorsch</surname><given-names>M</given-names></name><name name-style="western"><surname>Wolters</surname><given-names>J</given-names></name><name name-style="western"><surname>Busch</surname><given-names>M</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>H</given-names></name></person-group><article-title><italic toggle="yes">Brucella abortus</italic> 16S rRNA and lipid A reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class <italic toggle="yes">Proteobacteria</italic></article-title><source>J Bacteriol</source><year>1990</year><volume>172</volume><fpage>3569</fpage><lpage>3576</lpage><pub-id pub-id-type="pmid">2113907</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jb.172.7.3569-3576.1990</pub-id><pub-id pub-id-type="pmcid">PMC213329</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Monreal</surname><given-names>D</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Mainar-Jaime</surname><given-names>RC</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>Rough vaccines in animal brucellosis: structural and genetic basis and present status</article-title><source>Vet Res</source><year>2004</year><volume>35</volume><fpage>1</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">15099501</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1051/vetres:2003037</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu&#241;oz-Montesino</surname><given-names>C</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>E</given-names></name><name name-style="western"><surname>Rivers</surname><given-names>R</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Smith</surname><given-names>A</given-names></name><name name-style="western"><surname>Moraga-Cid</surname><given-names>G</given-names></name><name name-style="western"><surname>Folch</surname><given-names>H</given-names></name><name name-style="western"><surname>C&#233;spedes</surname><given-names>S</given-names></name><name name-style="western"><surname>O&#241;ate</surname><given-names>AA</given-names></name></person-group><article-title>Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of <italic toggle="yes">Brucella abortus</italic> induces SOD-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells</article-title><source>Infect Immun</source><year>2004</year><volume>72</volume><fpage>2081</fpage><lpage>2087</lpage><pub-id pub-id-type="pmid">15039330</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.72.4.2081-2087.2004</pub-id><pub-id pub-id-type="pmcid">PMC375181</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nymo</surname><given-names>IH</given-names></name><name name-style="western"><surname>Tryland</surname><given-names>M</given-names></name><name name-style="western"><surname>Godfroid</surname><given-names>J</given-names></name></person-group><article-title>A review of <italic toggle="yes">Brucella</italic> infection in marine mammals, with special emphasis on <italic toggle="yes">Brucella pinnipedialis</italic> in the hooded seal (<italic toggle="yes">Cystophora cristata</italic>)</article-title><source>Vet Res</source><year>2011</year><volume>42</volume><fpage>93</fpage><pub-id pub-id-type="pmid">21819589</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1297-9716-42-93</pub-id><pub-id pub-id-type="pmcid">PMC3161862</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Hara</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Collins</surname><given-names>DM</given-names></name><name name-style="western"><surname>de Lisle</surname><given-names>GW</given-names></name></person-group><article-title>Restriction endonuclease analysis of <italic toggle="yes">Brucella ovis</italic> and other <italic toggle="yes">Brucella</italic> species</article-title><source>Vet Microbiol</source><year>1985</year><volume>10</volume><fpage>425</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">2996213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0378-1135(85)90024-0</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>SC</given-names></name><name name-style="western"><surname>Harms</surname><given-names>JS</given-names></name><name name-style="western"><surname>Banai</surname><given-names>M</given-names></name><name name-style="western"><surname>Splitter</surname><given-names>GA</given-names></name></person-group><article-title>Recombinant <italic toggle="yes">Brucella abortus</italic> proteins that induce proliferation and gamma-interferon secretion by CD4<sup>+</sup> T cells from <italic toggle="yes">Brucella</italic>-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs</article-title><source>Cell Immunol</source><year>1996</year><volume>172</volume><fpage>262</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">8964089</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/cimm.1996.0241</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>SC</given-names></name><name name-style="western"><surname>Splitter</surname><given-names>GA</given-names></name></person-group><article-title>Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against <italic toggle="yes">Brucella abortus</italic> infection</article-title><source>Vaccine</source><year>1996</year><volume>14</volume><fpage>959</fpage><lpage>962</lpage><pub-id pub-id-type="pmid">8873388</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0264-410x(96)00018-7</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>SM</given-names></name><name name-style="western"><surname>Schurig</surname><given-names>GG</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>NN</given-names></name></person-group><article-title>Immune responses and protection against experimental challenge after vaccination of bison with <italic toggle="yes">Brucella abortus</italic> strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes</article-title><source>Clin Vaccine Immunol</source><year>2009</year><volume>16</volume><fpage>535</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">19176693</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CVI.00419-08</pub-id><pub-id pub-id-type="pmcid">PMC2668271</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>C</given-names></name></person-group><article-title>Immune responses and safety after dart or booster vaccination of bison with <italic toggle="yes">Brucella abortus</italic> strain RB51</article-title><source>Clin Vaccine Immunol</source><year>2012</year><volume>19</volume><fpage>642</fpage><lpage>648</lpage><pub-id pub-id-type="pmid">22461528</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CVI.00033-12</pub-id><pub-id pub-id-type="pmcid">PMC3346322</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pappas</surname><given-names>G</given-names></name><name name-style="western"><surname>Papadimitriou</surname><given-names>P</given-names></name><name name-style="western"><surname>Akritidis</surname><given-names>N</given-names></name><name name-style="western"><surname>Christou</surname><given-names>L</given-names></name><name name-style="western"><surname>Tsianos</surname><given-names>EV</given-names></name></person-group><article-title>The new global map of human brucellosis</article-title><source>Lancet Infect Dis</source><year>2006</year><volume>6</volume><fpage>91</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">16439329</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1473-3099(06)70382-6</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pasquevich</surname><given-names>KA</given-names></name><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name><name name-style="western"><surname>Garc&#237;a Samartino</surname><given-names>C</given-names></name><name name-style="western"><surname>Zwerdling</surname><given-names>A</given-names></name><name name-style="western"><surname>Coria</surname><given-names>LM</given-names></name><name name-style="western"><surname>Barrionuevo</surname><given-names>P</given-names></name><name name-style="western"><surname>Fossati</surname><given-names>CA</given-names></name><name name-style="western"><surname>Giambartolomei</surname><given-names>GH</given-names></name><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name></person-group><article-title>Immunization with recombinant <italic toggle="yes">Brucella</italic> species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells as well as systemic and oral protection against Brucella abortus infection</article-title><source>Infect Immun</source><year>2009</year><volume>77</volume><fpage>436</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">18981242</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.01151-08</pub-id><pub-id pub-id-type="pmcid">PMC2612246</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pizarro-Cerd&#225;</surname><given-names>J</given-names></name><name name-style="western"><surname>M&#233;resse</surname><given-names>S</given-names></name><name name-style="western"><surname>Parton</surname><given-names>RG</given-names></name><name name-style="western"><surname>van der Goot</surname><given-names>G</given-names></name><name name-style="western"><surname>Sola-Landa</surname><given-names>A</given-names></name><name name-style="western"><surname>Lopez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name></person-group><article-title><italic toggle="yes">Brucella abortus</italic> transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes</article-title><source>Infect Immun</source><year>1998</year><volume>66</volume><fpage>5711</fpage><lpage>5724</lpage><pub-id pub-id-type="pmid">9826346</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.66.12.5711-5724.1998</pub-id><pub-id pub-id-type="pmcid">PMC108722</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porte</surname><given-names>F</given-names></name><name name-style="western"><surname>Naroeni</surname><given-names>A</given-names></name><name name-style="western"><surname>Ouahrani-Bettache</surname><given-names>S</given-names></name><name name-style="western"><surname>Liautard</surname><given-names>JP</given-names></name></person-group><article-title>Role of the <italic toggle="yes">Brucella suis</italic> lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophages</article-title><source>Infect Immun</source><year>2003</year><volume>71</volume><fpage>1481</fpage><lpage>1490</lpage><pub-id pub-id-type="pmid">12595466</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.71.3.1481-1490.2003</pub-id><pub-id pub-id-type="pmcid">PMC148865</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qian</surname><given-names>J</given-names></name><name name-style="western"><surname>Bu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Lang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yan</surname><given-names>G</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>A safe and molecular-tagged <italic toggle="yes">Brucella canis</italic> ghosts confers protection against virulent challenge in mice</article-title><source>Vet Microbiol</source><year>2017</year><volume>204</volume><fpage>121</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">28532790</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vetmic.2017.04.027</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scholz</surname><given-names>HC</given-names></name><name name-style="western"><surname>Pfeffer</surname><given-names>M</given-names></name><name name-style="western"><surname>Witte</surname><given-names>A</given-names></name><name name-style="western"><surname>Neubauer</surname><given-names>H</given-names></name><name name-style="western"><surname>Al Dahouk</surname><given-names>S</given-names></name><name name-style="western"><surname>Wernery</surname><given-names>U</given-names></name><name name-style="western"><surname>Tomaso</surname><given-names>H</given-names></name></person-group><article-title>Specific detection and differentiation of <italic toggle="yes">Ochrobactrum anthropi</italic>, <italic toggle="yes">Ochrobactrum intermedium</italic> and <italic toggle="yes">Brucella</italic> spp. by a multi-primer PCR that targets the recA gene</article-title><source>J Med Microbiol</source><year>2008</year><volume>57</volume><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">18065669</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1099/jmm.0.47507-0</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schurig</surname><given-names>GG</given-names></name><name name-style="western"><surname>Roop</surname><given-names>RM</given-names><suffix>2nd</suffix></name><name name-style="western"><surname>Bagchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>S</given-names></name><name name-style="western"><surname>Buhrman</surname><given-names>D</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name></person-group><article-title>Biological properties of RB51; a stable rough strain of <italic toggle="yes">Brucella abortus</italic></article-title><source>Vet Microbiol</source><year>1991</year><volume>28</volume><fpage>171</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">1908158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0378-1135(91)90091-s</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schurig</surname><given-names>GG</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name><name name-style="western"><surname>Corbel</surname><given-names>MJ</given-names></name></person-group><article-title>Brucellosis vaccines: past, present and future</article-title><source>Vet Microbiol</source><year>2002</year><volume>90</volume><fpage>479</fpage><lpage>496</lpage><pub-id pub-id-type="pmid">12414166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-1135(02)00255-9</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sieira</surname><given-names>R</given-names></name><name name-style="western"><surname>Comerci</surname><given-names>DJ</given-names></name><name name-style="western"><surname>S&#225;nchez</surname><given-names>DO</given-names></name><name name-style="western"><surname>Ugalde</surname><given-names>RA</given-names></name></person-group><article-title>A homologue of an operon required for DNA transfer in <italic toggle="yes">Agrobacterium</italic> is required in <italic toggle="yes">Brucella abortus</italic> for virulence and intracellular multiplication</article-title><source>J Bacteriol</source><year>2000</year><volume>182</volume><fpage>4849</fpage><lpage>4855</lpage><pub-id pub-id-type="pmid">10940027</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jb.182.17.4849-4855.2000</pub-id><pub-id pub-id-type="pmcid">PMC111363</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>TM</given-names></name><name name-style="western"><surname>Costa</surname><given-names>EA</given-names></name><name name-style="western"><surname>Paix&#227;o</surname><given-names>TA</given-names></name><name name-style="western"><surname>Tsolis</surname><given-names>RM</given-names></name><name name-style="western"><surname>Santos</surname><given-names>RL</given-names></name></person-group><article-title>Laboratory animal models for brucellosis research</article-title><source>J Biomed Biotechnol</source><year>2011</year><volume>2011</volume><fpage>518323</fpage><pub-id pub-id-type="pmid">21403904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2011/518323</pub-id><pub-id pub-id-type="pmcid">PMC3043301</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singha</surname><given-names>H</given-names></name><name name-style="western"><surname>Mallick</surname><given-names>AI</given-names></name><name name-style="western"><surname>Jana</surname><given-names>C</given-names></name><name name-style="western"><surname>Fatima</surname><given-names>N</given-names></name><name name-style="western"><surname>Owais</surname><given-names>M</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>P</given-names></name></person-group><article-title>Co-immunization with interlukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu-Zn superoxide dismutase protein against <italic toggle="yes">Brucella abortus</italic></article-title><source>Vaccine</source><year>2011</year><volume>29</volume><fpage>4720</fpage><lpage>4727</lpage><pub-id pub-id-type="pmid">21565241</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2011.04.088</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stabel</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Mayfield</surname><given-names>JE</given-names></name><name name-style="western"><surname>Morfitt</surname><given-names>DC</given-names></name><name name-style="western"><surname>Wannemuehler</surname><given-names>MJ</given-names></name></person-group><article-title>Oral immunization of mice and swine with an attenuated <italic toggle="yes">Salmonella</italic> choleraesuis [delta <italic toggle="yes">cya-12</italic> delta(<italic toggle="yes">crp-cdt</italic>)<italic toggle="yes">19</italic>] mutant containing a recombinant plasmid</article-title><source>Infect Immun</source><year>1993</year><volume>61</volume><fpage>610</fpage><lpage>618</lpage><pub-id pub-id-type="pmid">8423090</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.61.2.610-618.1993</pub-id><pub-id pub-id-type="pmcid">PMC302771</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Starr</surname><given-names>T</given-names></name><name name-style="western"><surname>Child</surname><given-names>R</given-names></name><name name-style="western"><surname>Wehrly</surname><given-names>TD</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>B</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>S</given-names></name><name name-style="western"><surname>L&#243;pez-Otin</surname><given-names>C</given-names></name><name name-style="western"><surname>Virgin</surname><given-names>HW</given-names></name><name name-style="western"><surname>Celli</surname><given-names>J</given-names></name></person-group><article-title>Selective subversion of autophagy complexes facilitates completion of the <italic toggle="yes">Brucella</italic> intracellular cycle</article-title><source>Cell Host Microbe</source><year>2012</year><volume>11</volume><fpage>33</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">22264511</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chom.2011.12.002</pub-id><pub-id pub-id-type="pmcid">PMC3266535</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stevens</surname><given-names>MG</given-names></name><name name-style="western"><surname>Tabatabai</surname><given-names>LB</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name><name name-style="western"><surname>Cheville</surname><given-names>NF</given-names></name></person-group><article-title>Immune responses to superoxide dismutase and synthetic peptides of superoxide dismutase in cattle vaccinated with <italic toggle="yes">Brucella abortus</italic> strain 19 or RB51</article-title><source>Vet Microbiol</source><year>1994</year><volume>41</volume><fpage>383</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">7801538</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0378-1135(94)90034-5</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su&#225;rez-Esquivel</surname><given-names>M</given-names></name><name name-style="western"><surname>Ruiz-Villalobos</surname><given-names>N</given-names></name><name name-style="western"><surname>Jim&#233;nez-Rojas</surname><given-names>C</given-names></name><name name-style="western"><surname>Barquero-Calvo</surname><given-names>E</given-names></name><name name-style="western"><surname>Chac&#243;n-D&#237;az</surname><given-names>C</given-names></name><name name-style="western"><surname>V&#237;quez-Ruiz</surname><given-names>E</given-names></name><name name-style="western"><surname>Rojas-Campos</surname><given-names>N</given-names></name><name name-style="western"><surname>Baker</surname><given-names>KS</given-names></name><name name-style="western"><surname>Oviedo-S&#225;nchez</surname><given-names>G</given-names></name><name name-style="western"><surname>Amuy</surname><given-names>E</given-names></name><name name-style="western"><surname>Chaves-Olarte</surname><given-names>E</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>NR</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Guzm&#225;n-Verri</surname><given-names>C</given-names></name></person-group><article-title><italic toggle="yes">Brucella neotomae</italic> infection in humans, Costa Rica</article-title><source>Emerg Infect Dis</source><year>2017</year><volume>23</volume><fpage>997</fpage><lpage>1000</lpage><pub-id pub-id-type="pmid">28518028</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3201/eid2306.162018</pub-id><pub-id pub-id-type="pmcid">PMC5443450</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabatabai</surname><given-names>LB</given-names></name><name name-style="western"><surname>Pugh</surname><given-names>GW</given-names><suffix>Jr</suffix></name></person-group><article-title>Modulation of immune responses in Balb/c mice vaccinated with <italic toggle="yes">Brucella abortus</italic> Cu-Zn superoxide dismutase synthetic peptide vaccine</article-title><source>Vaccine</source><year>1994</year><volume>12</volume><fpage>919</fpage><lpage>924</lpage><pub-id pub-id-type="pmid">7526568</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0264-410x(94)90035-3</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabatabai</surname><given-names>LB</given-names></name><name name-style="western"><surname>Pugh</surname><given-names>GW</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Stevens</surname><given-names>MG</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>M</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>TJ</given-names></name></person-group><article-title>Monophosphoryl lipid A-induced immune enhancement of <italic toggle="yes">Brucella abortus</italic> salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice</article-title><source>Am J Vet Res</source><year>1992</year><volume>53</volume><fpage>1900</fpage><lpage>1907</lpage><pub-id pub-id-type="pmid">1456539</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabynov</surname><given-names>K</given-names></name><name name-style="western"><surname>Yespembetov</surname><given-names>B</given-names></name><name name-style="western"><surname>Matikhan</surname><given-names>N</given-names></name><name name-style="western"><surname>Ryskeldinova</surname><given-names>S</given-names></name><name name-style="western"><surname>Zinina</surname><given-names>N</given-names></name><name name-style="western"><surname>Kydyrbayev</surname><given-names>Z</given-names></name><name name-style="western"><surname>Assanzhanova</surname><given-names>N</given-names></name><name name-style="western"><surname>Tabynov</surname><given-names>K</given-names></name><name name-style="western"><surname>Renukaradhya</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Mukhitdinova</surname><given-names>G</given-names></name><name name-style="western"><surname>Sansyzbay</surname><given-names>A</given-names></name></person-group><article-title>First evaluation of an influenza viral vector based <italic toggle="yes">Brucella abortus</italic> vaccine in sheep and goats: assessment of safety, immunogenicity and protective efficacy against <italic toggle="yes">Brucella melitensis</italic> infection</article-title><source>Vet Microbiol</source><year>2016</year><volume>197</volume><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">27938677</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vetmic.2016.11.001</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tasiame</surname><given-names>W</given-names></name><name name-style="western"><surname>Emikpe</surname><given-names>BO</given-names></name><name name-style="western"><surname>Folitse</surname><given-names>RD</given-names></name><name name-style="western"><surname>Fofie</surname><given-names>CO</given-names></name><name name-style="western"><surname>Burimuah</surname><given-names>V</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>S</given-names></name><name name-style="western"><surname>Awuni</surname><given-names>JA</given-names></name><name name-style="western"><surname>Afari</surname><given-names>E</given-names></name><name name-style="western"><surname>Yebuah</surname><given-names>N</given-names></name><name name-style="western"><surname>Wurapa</surname><given-names>F</given-names></name></person-group><article-title>The prevalence of brucellosis in cattle and their handlers in North Tongu District of Volta Region, Ghana</article-title><source>Afr J Infect Dis</source><year>2016</year><volume>10</volume><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">28480445</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21010/ajid.v10i2.6</pub-id><pub-id pub-id-type="pmcid">PMC5411985</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>AW</given-names></name><name name-style="western"><surname>McDiarmid</surname><given-names>A</given-names></name></person-group><article-title>The stability of the avirulent characters of <italic toggle="yes">Brucella abortus</italic> strain 19 and strain 45/20 in lactating and pregnant cows</article-title><source>Vet Rec</source><year>1949</year><volume>61</volume><fpage>317</fpage><lpage>318</lpage></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toth</surname><given-names>TE</given-names></name><name name-style="western"><surname>Cobb</surname><given-names>JA</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>SM</given-names></name><name name-style="western"><surname>Roop</surname><given-names>RM</given-names></name><name name-style="western"><surname>Schurig</surname><given-names>GG</given-names></name></person-group><article-title>Selective humoral immune response of Balb/C mice to <italic toggle="yes">Brucella abortus</italic> proteins expressed by vaccinia virus recombinants</article-title><source>Vet Microbiol</source><year>1995</year><volume>45</volume><fpage>171</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">7571368</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0378-1135(95)00047-e</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trant</surname><given-names>CG</given-names></name><name name-style="western"><surname>Lacerda</surname><given-names>TL</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>NB</given-names></name><name name-style="western"><surname>Azevedo</surname><given-names>V</given-names></name><name name-style="western"><surname>Rosinha</surname><given-names>GM</given-names></name><name name-style="western"><surname>Salcedo</surname><given-names>SP</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>SC</given-names></name></person-group><article-title>The <italic toggle="yes">Brucella abortus</italic> phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice</article-title><source>Infect Immun</source><year>2010</year><volume>78</volume><fpage>2283</fpage><lpage>2291</lpage><pub-id pub-id-type="pmid">20194591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.01433-09</pub-id><pub-id pub-id-type="pmcid">PMC2863508</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tukana</surname><given-names>A</given-names></name><name name-style="western"><surname>Gummow</surname><given-names>B</given-names></name></person-group><article-title>Dairy farm demographics and management factors that played a role in the re-emergence of brucellosis on dairy cattle farms in Fiji</article-title><source>Trop Anim Health Prod</source><year>2017</year><volume>49</volume><fpage>1171</fpage><lpage>1178</lpage><pub-id pub-id-type="pmid">28528495</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11250-017-1314-8</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ugalde</surname><given-names>JE</given-names></name><name name-style="western"><surname>Comerci</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Leguizam&#243;n</surname><given-names>MS</given-names></name><name name-style="western"><surname>Ugalde</surname><given-names>RA</given-names></name></person-group><article-title>Evaluation of <italic toggle="yes">Brucella abortus</italic> phosphoglucomutase (<italic toggle="yes">pgm</italic>) mutant as a new live rough-phenotype vaccine</article-title><source>Infect Immun</source><year>2003</year><volume>71</volume><fpage>6264</fpage><lpage>6269</lpage><pub-id pub-id-type="pmid">14573645</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.71.11.6264-6269.2003</pub-id><pub-id pub-id-type="pmcid">PMC219583</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ugalde</surname><given-names>JE</given-names></name><name name-style="western"><surname>Czibener</surname><given-names>C</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>MF</given-names></name><name name-style="western"><surname>Ugalde</surname><given-names>RA</given-names></name></person-group><article-title>Identification and characterization of the <italic toggle="yes">Brucella abortus</italic> phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication</article-title><source>Infect Immun</source><year>2000</year><volume>68</volume><fpage>5716</fpage><lpage>5723</lpage><pub-id pub-id-type="pmid">10992476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.68.10.5716-5723.2000</pub-id><pub-id pub-id-type="pmcid">PMC101528</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Campen</surname><given-names>H</given-names></name><name name-style="western"><surname>Rhyan</surname><given-names>J</given-names></name></person-group><article-title>The role of wildlife in diseases of cattle</article-title><source>Vet Clin North Am Food Anim Pract</source><year>2010</year><volume>26</volume><fpage>147</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">20117548</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cvfa.2009.10.008</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Velikovsky</surname><given-names>CA</given-names></name><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name><name name-style="western"><surname>Giambartolomei</surname><given-names>GH</given-names></name><name name-style="western"><surname>Goldbaum</surname><given-names>FA</given-names></name><name name-style="western"><surname>Estein</surname><given-names>S</given-names></name><name name-style="western"><surname>Bowden</surname><given-names>RA</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>L</given-names></name><name name-style="western"><surname>Fossati</surname><given-names>CA</given-names></name><name name-style="western"><surname>Spitz</surname><given-names>M</given-names></name></person-group><article-title>A DNA vaccine encoding lumazine synthase from <italic toggle="yes">Brucella abortus</italic> induces protective immunity in BALB/c mice</article-title><source>Infect Immun</source><year>2002</year><volume>70</volume><fpage>2507</fpage><lpage>2511</lpage><pub-id pub-id-type="pmid">11953389</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.70.5.2507-2511.2002</pub-id><pub-id pub-id-type="pmcid">PMC127889</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vershilova</surname><given-names>PA</given-names></name></person-group><article-title>The use of live vaccine for vaccination of human beings against brucellosis in the USSR</article-title><source>Bull World Health Organ</source><year>1961</year><volume>24</volume><fpage>85</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">13780996</pub-id><pub-id pub-id-type="pmcid">PMC2555373</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wernery</surname><given-names>U</given-names></name></person-group><article-title>Camelid brucellosis: a review</article-title><source>Rev Sci Tech</source><year>2014</year><volume>33</volume><fpage>839</fpage><lpage>857</lpage><pub-id pub-id-type="pmid">25812208</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.20506/rst.33.3.2322</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winter</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Rowe</surname><given-names>GE</given-names></name><name name-style="western"><surname>Duncan</surname><suffix>JR</suffix></name><name name-style="western"><surname>Eis</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Widom</surname><given-names>J</given-names></name><name name-style="western"><surname>Ganem</surname><given-names>B</given-names></name><name name-style="western"><surname>Morein</surname><given-names>B</given-names></name></person-group><article-title>Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against <italic toggle="yes">Brucella abortus</italic> in mice</article-title><source>Infect Immun</source><year>1988</year><volume>56</volume><fpage>2808</fpage><lpage>2817</lpage><pub-id pub-id-type="pmid">2844673</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.56.11.2808-2817.1988</pub-id><pub-id pub-id-type="pmcid">PMC259654</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winter</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Schurig</surname><given-names>GG</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>SM</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name><name name-style="western"><surname>Bevins</surname><given-names>JS</given-names></name><name name-style="western"><surname>Enright</surname><given-names>FM</given-names></name><name name-style="western"><surname>Elzer</surname><given-names>PH</given-names></name><name name-style="western"><surname>Kopec</surname><given-names>JD</given-names></name></person-group><article-title>Protection of BALB/c mice against homologous and heterologous species of <italic toggle="yes">Brucella</italic> by rough strain vaccines derived from <italic toggle="yes">Brucella melitensis</italic> and <italic toggle="yes">Brucella suis</italic> biovar 4</article-title><source>Am J Vet Res</source><year>1996</year><volume>57</volume><fpage>677</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">8723881</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Hudson</surname><given-names>M</given-names></name><name name-style="western"><surname>Walters</surname><given-names>N</given-names></name><name name-style="western"><surname>Bargatze</surname><given-names>RF</given-names></name><name name-style="western"><surname>Pascual</surname><given-names>DW</given-names></name></person-group><article-title>Selection of protective epitopes for <italic toggle="yes">Brucella melitensis</italic> by DNA vaccination</article-title><source>Infect Immun</source><year>2005</year><volume>73</volume><fpage>7297</fpage><lpage>7303</lpage><pub-id pub-id-type="pmid">16239526</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.73.11.7297-7303.2005</pub-id><pub-id pub-id-type="pmcid">PMC1273852</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Skyberg</surname><given-names>JA</given-names></name><name name-style="western"><surname>Cao</surname><given-names>L</given-names></name><name name-style="western"><surname>Clapp</surname><given-names>B</given-names></name><name name-style="western"><surname>Thornburg</surname><given-names>T</given-names></name><name name-style="western"><surname>Pascual</surname><given-names>DW</given-names></name></person-group><article-title>Progress in <italic toggle="yes">Brucella</italic> vaccine development</article-title><source>Front Biol (Beijing)</source><year>2013</year><volume>8</volume><fpage>60</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">23730309</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11515-012-1196-0</pub-id><pub-id pub-id-type="pmcid">PMC3666581</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yin</surname><given-names>J</given-names></name><name name-style="western"><surname>Guo</surname><given-names>D</given-names></name><name name-style="western"><surname>Lang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against <italic toggle="yes">Brucella melitensis</italic> infection</article-title><source>FEMS Immunol Med Microbiol</source><year>2011</year><volume>61</volume><fpage>159</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">21166726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1574-695X.2010.00758.x</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Summary of <italic toggle="yes">Brucella</italic> vaccine and their properties</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jvs-18-281-i001.jpg"/></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Summary of hosts in vaccine development and trials</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jvs-18-281-i002.jpg"/></table-wrap></floats-group></article></pmc-articleset>